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DEDICATION 
TO MY PARENTS AND MY HUSBAND 
2 
INTRODUCTION 
Cholesterol is required for normal cell function. It 
is the precursor of steroid hormones and bile acids and is a 
major component of membranes and plasma lipoproteins. 
However, it is also a major constituent of atherosclerotic 
plaques and most gallstones. 
A major disease related to cholesterol is coronary 
heart disease (CHD), which is the leading cause of death in 
the United States (Levy, 1981). Most CHD is caused by 
atherosclerosis, a slowly progressive disease of the large 
arteries that begins early in life but rarely produces 
symptoms until middle age. Often the disease goes 
undetected until the time of the first heart attack, and 
this first heart attack is often fatal. So, the major 
progress against this disease should focus on finding 
preventive measures. A number of risk factors have been 
identified. Cigarette smoking, high blood pressure, and 
high blood cholesterol levels are the most clearly 
established of these factors. Risk is greater in men, 
increases with age, and has a strong genetic component. 
Obesity, diabetes mellitus, physical inactivity and behavior 
pattern are also risk factors (Consensus Conference, 1985). 
Although some factors such as sex, age and genetics cannot 
be changed, others may be modified. Epidemiology and human 
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and animal experimentation suggest that blood cholesterol 
and thus CHD incidence can be lowered by dietary 
modifications. 
Epidemiology 
The mortality of CHD in this country increased during 
the first half of this century, stabilized in 1964, declined 
after 1968, and is still declining (Levy, 1981). Coinciding 
with such change was a steady rise in the consumption of 
animal fats both from dairy products and meats before the 
1950s and a decrease in the consumption of animal fats and 
an increase in the consumption of polyunsaturated fat from 
vegetable sources afterwards (Brown and Karmally, 1985). 
Blood cholesterol also changed during that interval. Data 
from the National Health and Nutrition Examination Surveys 
(NHANES) (National Center for Health Statistics, 1987) 
showed that age-adjusted mean serum cholesterol levels 
decreased by 6 to 8 mg/dl, or 3 to 4 %, between the 1960 to 
1962 and the 1976 to 1980 surveys. The parallel changes in 
CHD incidence, diet trend and blood cholesterol levels 
indicated that there might be a causal relationship among 
them. Although the discovery of new drugs, advancement of 
surgical techniques and improvement of medical services can 
explain part of the decline in CHD mortality, the importance 
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of identification and modification of risk factors such as 
cigarette smoking cessation, hypertension control, diet 
change and reduction in blood cholesterol level cannot be 
ignored (Levy, 1981). An apparent decline in CHD mortality 
happened only in those countries with an aggressive approach 
to risk factor change. In fact, unlike the United States, 
Australia and Canada, where changes have taken place, some 
countries including the Soviet Union, Ireland, Scotland, 
Germany, Denmark and some Eastern Europe nations have seen 
J 
increasing death rates from CHD (Levy, 1984). The 
experience of North Karelia, the most easterly county of 
Finland, is another example. North Karelia had the highest 
death rate from CHD in the world in 1971. A community 
program was then set up and everyone was advised to stop 
smoking, eat less fat and more vegetables, avoid obesity, 
and have their blood pressure checked. By 1979 coronary 
mortality had fallen by 24% in men and 51% in women, a 
significantly greater fall than the general decline in 
coronary deaths in Finland during the same period (Truswell, 
1985). 
Several studies have been conducted to search for the 
association between cardiovascular mortality and food intake 
among countries. A strong correlation was found between 
cardiovascular mortality and percentage calories from fat 
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(Lopez-S et al., 1966), percentage calories from saturated 
fat (Lopez-S et al., 1966; Keys, 1970) and egg consumption 
(Armstrong et al., 1975). Similar findings were reported 
comparing vegetarians and nonvegetarians (Sacks et al., 
1975). Comparison of individuals within populations, 
however, failed to find a strong association between diet 
and cardiovascular mortality (McGill et al., 1981). 
Thirty years of follow-up from the Framingham study 
(Anderson et al., 1987) has provided a strong proof that 
cardiovascular mortality is positively related to blood 
cholesterol level. Under age 50 years, cardiovascular death 
increased 9% for each 10 mg/dl increase in blood cholesterol 
concentration although no such relationship was found after 
age 50 years as the data were confounded by people whose 
cholesterol levels were falling due to certain diseases 
predisposing to death. Comparisons of various countries 
throughout the world also revealed a direct correlation 
between blood cholesterol levels and cardiovascular 
mortality. No population has been reported to have a high 
rate of coronary heart disease and low blood cholesterol 
levels (Consensus Conference, 1985). Stamler et al. (1986) 
concluded that the relationship between serum cholesterol 
concentration and CHD mortality was not a threshold one, but 
rather was a continuously graded one with increased risk 
confined to the two highest quintiles. 
6 
Results of epidemiology studies on the relationship 
between dietary fats and blood cholesterol levels were not 
quite consistent. A positive correlation was identified 
between average dietary cholesterol or saturated fat intake 
and average plasma cholesterol concentrations when 
comparisons were made among population groups (McGill et 
al., 1981). Studies on Japanese populations also supported 
this conclusion. In the Japanese fishing villages of Kyushu 
and Tanushimaru, people ate rice supplemented by fish as 
their major food. The diet contained 10% of calories (Kcal) 
from fat and 3% from saturated fat. Their blood cholesterol 
averaged less than 170 mg/dl (Kimura, 1967). The urban 
Japanese in Hiroshima and Nagasaki ate 15% of calories from 
fat and 7% from saturated fat, and their blood cholesterol 
averaged 181 mg/dl (Kagan et al., 1974). The Japanese who 
have migrated to Honolulu and San Francisco increased their 
fat consumption; 23-26% of Kcal in their diet came from fat, 
and their average blood cholesterol concentration was 228 
mg/dl (Worth et al., 1975). The incidence of nonfatal 
myocardial infarction and CHD death among Japanese men had 
tripled in the population moving to California. Such 
conclusions, however, could not be drawn when comparisons 
were made among individuals within the population (Morris et 
al., 1963; Hodgson et al., 1976). McGill (1979) and Keys 
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(1970) interpreted this discrepancy as a natural consequence 
of the large within-subject variation in serum cholesterol 
levels and measurement errors, and the lack of association 
did not negate a real causal relationship between dietary 
fat and serum cholesterol concentration or CHD mortality. 
Glueck (1979a and b) also pointed out that the difference in 
nutrient intake within a population group was relatively 
small, recent diet habits did not necessarily represent 
lifetime patterns, and it was misleading to relate recent 
dietary practice to the risk of CHD since the development of 
atherosclerosis took decades to occur. 
Human Experimentation 
Controlled metabolic studies 
Controlled human studies have clearly demonstrated that 
diets in which polyunsaturated fats have been substituted 
for saturated fats lowered serum total and low density 
lipoprotein (LDL) cholesterol levels in healthy subjects 
(Shepherd et al., 1978 and 1980; Kraemer et al., 1982; 
Blaton et al., 1984; Reiser et al., 1985) as well as in 
hypercholesterolemic patients (Blaton et al., 1984), but the 
effects on high density lipoprotein (HDL) cholesterol were 
inconsistent. Some reported a decrease (Shepherd et al., 
1978 and 1980), some reported no change (Kraemer et al., 
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1982) and some reported an increase (Blaton et al., 1984). 
Such discrepancies might be due to differences in fat 
sources, ratio of polyunsaturated to saturated fat (P/S), 
experimental subjects and experimental design. Several 
mechanisms have been proposed to explain the 
hypocholesterolemic effect of polyunsaturated fats. These 
include increasing fecal excretion of bile acids and neutral 
sterols (Wood et al., 1966), shift of cholesterol from 
plasma to tissues due to greater volume of polyunsaturated 
fatty acids in the lipoprotein particles (Glueck, 1979a) and 
altering the production (Vega et al., 1982) or clearance 
(Shepherd et al., 1980) of LDL from the plasma. It is 
possible that the hypocholesterolemic action of 
polyunsaturated fat diets is effected by multiple mechanisms 
the expression of which may vary from person to person 
(Shepherd et al., 1980). 
The discoveries that Greenland Eskimos had a low 
incidence of cardiovascular diseases and that might be 
related to their high intake of marine lipids (Dyerberg and 
Bang, 1982) have stimulated many studies on fish oil. Fish 
oil was reported to be anti-thrombotic (Herold and Kinsella, 
1986; Knapp et al., 1986; Norum and Drevon, 1986). Its 
effects on cholesterol metabolism, however, were not very 
large. Nestel (1986) reported a cholesterol-lowering effect 
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of fish oil (40 g of MaxEPA per day) in plasma very low 
density lipoprotein (VLDL), LDL and HDL. He also found 
lower apoprotein (apo) A-2 and apo B levels with fish oil 
intake. Sanders et al. (1985) and Sullivan et al. (1986) 
used a lower dose of fish oil (15 g of MaxEPA per day) and 
found different results. LDL-cholesterol and apo B were 
higher with fish oil supplementation in both normal and 
hypertriglyceridemia patients. So, the cholesterol-lowering 
effect of fish oil occurred only at very high doses. Herold 
and Kinsella (1986) warned that the health professionals 
should consider the potentially deleterious effects of fish 
oil when making recommendations on fish oil supplementation. 
These could result from excessive oxidation, vitamin E 
deficiency, vitamin A and D excesses, or increased intake of 
contaminants such as PCBs and DDT. 
Dietary effects of monounsaturated fats on cholesterol 
metabolism have long been a neglected area. People used to 
think of monounsaturated fats as being neutral in 
cholesterol metabolism. The fact that low fat (Grundy, 
1986) or high polyunsaturated fat diets frequently reduced 
plasma cholesterol as well as HDL-cholesterol encouraged the 
search for a diet which did not reduce the protective 
lipoprotein HDL while reducing plasma cholesterol. 
Epidemiologic study indicated a low incidence of coronary 
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heart disease and low plasma cholesterol levels in the 
Mediterranean countries, which might be due in part to the 
greater use of olive oil, a high monounsaturated fat oil 
(Keys, 1970). Mattson and Grundy (1983) and Grundy (1986) 
reported that monounsaturated fats lowered plasma 
cholesterol and LDL-cholesterol, but had no effect on HDL-
cholesterol. The cholesterol-lowering effect was described 
as at least as effective as a diet low in fat and high in 
carbohydrate. More research in this area needs to be done 
to verify the findings. 
The effects of dietary cholesterol on plasma 
cholesterol levels are somewhat controversial. Mattson et 
al. (1972) found a linear relationship between dietary 
cholesterol and elevation of serum cholesterol using egg 
yolk to modify the amount of dietary cholesterol. The 
elevation in serum cholesterol was about 12 mg/dl for each 
100 mg of cholesterol added per 1000 Kcal over the range of 
0-317 mg of cholesterol per 1000 Kcal per day. Ginsberg et 
al. (1981), however, found no effect of dietary cholesterol 
on concentrations of plasma cholesterol and LDL-cholesterol, 
and rate of production or clearance of apo B in VLDL and LDL 
in their subjects. The conflicting results brought about 
the recognition of responders and nonresponders to dietary 
cholesterol and raised the question about the role of 
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genetics in the regulation of cholesterol metabolism. This 
variability did not appear to be due to individual 
differences in the absorption of dietary cholesterol as the 
mass of cholesterol absorbed was linearly related to the 
amount of dietary cholesterol in both normocholesterolemic 
(Simons et al., 1978) and hypercholesterolemic patients 
(Connor and Lin, 1974). It is possible that other 
mechanisms such as changes in endogenous cholesterol 
synthesis, excretion of cholesterol or bile acids or 
lipoprotein metabolism are working differently in the 
responders and nonresponders. 
Intervention trials 
A number of intervention trials have been carried out 
to test the diet-heart hypothesis. The Chicago Coronary 
Prevention Trial (Farinaro et al., 1977), the Oslo study 
(Hjermann et al., 1981) and the Multiple Risk Factor 
Intervention Trial (MRFIT) (Dolecek et al., 1986) all 
demonstrated that blood cholesterol can be lowered by 
decreasing saturated fat and cholesterol and increasing 
polyunsaturated fats in the diet. 
The beneficial effects of lowering blood cholesterol 
were further supported by the results of the Lipid Research 
Clinics Coronary Primary Prevention Trial (CPPT) (The Lipid 
Research Clinics Coronary Primary Prevention Trial Results I 
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and II, 1984a and b). In this study, cholesterol-lowering 
was achieved by a combination of diet and cholestyramine in 
the treatment group and diet alone in the control group. 
They found that a 1% reduction in plasma cholesterol was 
accompanied by a 2% reduction in the incidence of coronary 
heart disease morbidity and mortality in men with high blood 
cholesterol levels. Kronmal (1985) criticized the way this 
conclusion was reached. First, the criterion to test the 
difference between the placebo and the treatment groups was 
originally set at 0.01 level, but the results were reported 
using a one-sided 0.05 level. Second, the use of percent 
change in plasma cholesterol could lead to "spurious" 
correlation. In other words, the relationship between the 
risk of a CHD end point and the percent cholesterol change 
might not be caused by the absolute change in plasma 
cholesterol, but rather to the relationship between the 
baseline cholesterol level and the CHD event rate. 
Rahimtoola (1985) questioned the efficacy of reduction of 
hypercholesterolemia since the difference in CHD incidence 
between the two groups was small. Anyway, CPPT provided 
important results concerning the effects of diet plus 
cholestyramine on the lowering of plasma cholesterol and 
LDL-cholesterol levels and its effects on CHD mortality and 
morbidity in hyperlipidemic men. 
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Animal Models 
Both the controlled metabolic studies and clinical 
intervention trials have suggested that diet can affect 
blood cholesterol and high blood cholesterol has a causal 
relationship with atherosclerosis. However, because of 
ethical reasons and limitations, human studies alone are not 
sufficient to investigate the mechanisms of the 
relationships. A number of animal models have been 
developed to provide a means for mechanistic study. There 
are wide variations in cholesterol metabolism among species. 
No one animal model is a perfect model for the human. But 
animal models do provide valuable information of what may be 
happening in humans. 
Squirrel monkey 
Although marked differences in plasma cholesterol 
concentrations were not apparent among squirrel monkeys fed 
cholesterol-free diets, marked differences occurred when 
they were fed a high cholesterol diet (1 mg/Kcal) (Clarkson 
et al., 1971). Hyperresponders developed considerable 
hypercholesterolemia with total serum cholesterol levels in 
the range of 700 to 1,000 mg/dl, while hyporesponders were 
around 200 to 300 mg/dl, and still others were in between. 
Moreover, the hyporesponders fed high cholesterol diets for 
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long periods of time had minimal arterial lesions while 
hyperresponders fed the same diet had markedly exacerbated 
atherosclerosis. By different combinations of matings of 
hyperresponders and hyporesponders, Clarkson et al. (1971) 
showed that more than half of the variability in plasma 
cholesterol values of the progeny when challenged with a 
high cholesterol diet was attributable to genetic factors. 
Lofland et al. (1972) demonstrated that hyporesponders fed a 
cholesterol-containing diet had a greater and more rapid 
increase in fecal excretion of bile salts than did 
hyperresponders. They speculated that the mechanism of 
control of the level of plasma cholesterol was related to 
the rate of conversion of cholesterol to bile acids. Jones 
et al. (1975) further studied the mechanism by feeding 
hyper- and hyporesponders safflower oil or butter as 40% of 
calories. Hyperresponders had higher plasma cholesterol 
than hyporesponders, and butter induced a greater response 
than did safflower oil. Also, hyperresponders absorbed a 
higher mean percentage of ingested cholesterol and were more 
sensitive to a given amount of absorbed cholesterol than 
were hyporesponders. 
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Rhesus monkey 
Rhesus monkeys showed marked individual differences in 
serum cholesterol levels not only when fed an atherogenic 
diet (high saturated fat and high cholesterol) but also when 
fed a basal diet. Unlike squirrel monkeys, hyperresponders 
of rhesus monkeys excreted more bile acids in the feces than 
did hyporesponders when fed an atherogenic diet, and both 
groups had similar excretion of neutral sterols (Eggen, 
1976). So, differences in the excretion of bile acids could 
not explain the higher plasma cholesterol level in 
hyperresponders. Furthermore, endogenous cholesterol 
synthesis could not explain the differences either, as 
hyperresponders had a greater degree of feedback inhibition 
of cholesterol biosynthesis (Bhattacharyya and Eggen, 1981). 
The major difference was intestinal absorption; 
hyperresponders absorbed more cholesterol than did 
hyporesponders (Bhattacharyya and Eggen, 1980 and 1981). 
The investigators concluded that such differences might 
reflect differences in rates of one or more of the 
biochemical reactions involved in the absorption process, 
differences in surface area of the intestinal lumen or 
differences in motility of the intestine. Baker et al. 
(1983) studied the lipoprotein profiles in rhesus monkeys. 
They reported higher plasma apo B and E and lower A-1 
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concentrations in hyperresponders than in hyporesponders fed 
a high fat (38% Real) and high cholesterol (0.4 mg/Kcal) 
diet. 
Baboon 
The baboon also showed variability in serum cholesterol 
when fed an atherogenic diet as did squirrel and rhesus 
monkeys, and its serum cholesterol and HDL-cholesterol 
responses to diet were heritable (Flow et al., 1981). Sire 
effects were observed for serum cholesterol concentration, 
cholesterol turnover rate, cholesterol production rate and 
several cholesterol pool parameters derived from a two-pool 
model (Plow and Mott, 1982). Flow and Mott (1984) provided 
evidence that the size of the rapidly miscible pool of body 
cholesterol and the movement of cholesterol in and out of 
that pool were influenced to a large degree by the same 
genes that regulate the plasma concentration of HDL. The 
differences among sire progeny groups in cholesterol 
metabolism were likely due to genetically mediated 
differences in the hepatic receptors or enzymes which 
regulated HDL-cholesterol metabolism. 
Pigeon 
Two strains of Show Racer Pigeons (SR) were identified 
and selectively bred as hypo (SR-39) and hyper (SR-37) 
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responders to diet-induced hypercholesterolemia and 
atherosclerosis (Wagner et al,, 1973). The defect in the 
SR-37 strain was not overproduction of cholesterol since 
SR-39 pigeons displayed much higher hepatic 
hydroxymethylglutaryl coenzyme A reductase activity (HMGR) 
(a rate-limiting enzyme in cholesterol synthesis) than did 
the SR-37 strain (Hulcher et al., 1976). A turnover study 
by Wagner and Clarkson (1974) indicated that SR-39 pigeons 
had a larger rate constant for excretion of cholesterol from 
pool A, whereas SR-37 pigeons had a much lower rate 
constant. Hulcher and Margolis (1982) further studied 
cholesterol metabolism in these two strains of pigeons by 
assaying the activity of cholesterol 7a-hydroxylase (COH), a 
key regulatory enzyme in bile acid synthesis. They found 
that the enzyme activity was consistently lower in SR-37 
than in SR-39 pigeons no matter whether they were fed a 
cholesterol-free diet or a cholesterol-containing diet. The 
data implied that the basis for inefficient regulation of 
serum cholesterol in the SR-37 strain resided in inefficient 
up-regulation of the activity or synthesis of cholesterol 
7a-hydroxylase. 
St. Clair et al. (1986) studied the relationship 
between /3-VLDL and atherosclerosis in White Carneau (WC) 
(atherosclerosis-susceptible) and Show Racer (SR) 
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(atherosclerosis-resistant) pigeons. g-VLDL is a 
cholesteryl ester-rich beta-migrating VLDL present in 
animals fed cholesterol and is suspected as the primary 
atherogenic lipoprotein in cholesterol-fed animals. The two 
strains of pigeon had similar plasma cholesterol levels but 
different susceptibility to atherosclerosis. No 
relationship between /Î-VLDL concentration or the ability of 
/3-VLDL to stimulate macrophage cholesterol accumulation in 
vitro and the extent of atherosclerosis was found. The 
authors concluded that differences in susceptibility to 
atherosclerosis among pigeons probably were mediated at the 
level of the arterial wall, perhaps by genetic differences 
that influence the way an individual animal's arterial cells 
(endothelial, smooth muscle, macrophage) interact with 
specific plasma lipoproteins. 
Quail 
Hypercholesterolemia was induced in a strain of 
Japanese quail by feeding 1% of cholesterol or 1% of 
cholesterol plus 0.5% of cholic acid in the diet. Radcliffe 
and Liebsch (1985) found that the severity of 
atherosclerosis and arterial cholesterol concentration were 
positively correlated with serum cholesterol concentration. 
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Miniature swine 
In a 2 by 2 factorial experiment, Walsh-Hentges et al. 
(1985a and b) studied the effects of protein (soy protein / 
egg white) and fat (beef tallow / soybean oil) on plasma 
lipid and lipoprotein metabolism in miniature swine. They 
found that proteins and fats affected cholesterol metabolism 
by different mechanisms. The dietary fat source affected 
plasma lipid concentration and tissue cholesterol 
accumulation while the dietary protein source affected the 
catabolic rate of LDL. Compared to beef tallow, soybean oil 
consumption resulted in decreased plasma cholesterol 
concentration, increased LDL-cholesterol concentration, 
decreased HDL-cholesterol concentration, and greater 
accumulation of cholesterol in aorta, heart, large and small 
intestines, liver, adipose tissue and skeletal muscle. Egg 
white consumption, on the other hand, decreased fractional 
catabolic rate of LDL-cholesterol compared to soy protein. 
LDL disappearance was higher when vegetable products were 
fed, i.e., soy protein or soybean oil, which suggested that 
receptor-dependent degradation might be sensitive to changes 
in the degree of unsaturation of dietary lipid and to 
changes in protein source. 
Clow et al. (1987) studied the effects of dietary fats 
(SFA diet; 40 en% beef fat, P/S=0.17; PUFA: 8 en% beef 
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fat, 32 en% safflower oil, P/S=4.16) on cholesterol and bile 
acid kinetics in miniature swine. Cannulae were implanted 
to allow sampling of the portal vein, aorta and jejunal 
contents. Diets did not affect the half-life of serum 
cholesterol, but the fractional turnover rate from pool 2 to 
pool 1 was greater for the SFA group than the PUPA group. 
The PUFA-fed pigs had a larger cholesterol pool and greater 
flow rate between pools compared to SFA-fed pigs. Jejunal 
cholesterol kinetics were similar to those for serum from 
SFA-fed pigs, but not PUFA-fed pigs in which the flow rates 
between pools in jejunal pools were lower than those in 
serum pools. Bile acid specific activity reached a maximum 
within 15 hours and showed a plateau for about two weeks 
before beginning to decrease. The authors concluded that 
pools of cholesterol available in the liver for resecretion 
to the serum, excretion into the gut and formation of bile 
acids were not in rapid equilibrium. 
Rabbit 
Beynen et al. studied the responses of serum 
cholesterol to diet in random-bred (1986a) and inbred 
(1986b) rabbits. Among random-bred rabbits, individual 
variations in cholesterolemic responses to dietary fat and 
cholesterol were large, and the association between 
responses to dietary cholesterol and responses to dietary 
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coconut oil (high saturated fat) was weak. Hyper- and 
hyporesponders to dietary cholesterol and fat were also 
found in inbred rabbits. The hyperresponders to dietary 
cholesterol were also hyperresponders to dietary coconut fat 
and casein. The effects of monounsaturated fats, 
polyunsaturated fats and fish oil were also studied in 
rabbits. Compared to butter (high saturated fat), both corn 
oil (high polyunsaturated fat) and olive oil (high 
monounsaturated fat) caused a decrease in plasma cholesterol 
and an increase in HDL-cholesterol, and the effect of corn 
oil was higher than that of olive oil (Nasi et al., 1986). 
Beynen et al. (1987) also found an intermediate effect of 
olive oil between corn oil and coconut fat in both plasma 
total and HDL-cholesterol. Ten percent menhaden oil (a fish 
oil) or menhaden oil plus 1% cholesterol added to the diet 
of rabbits caused an increase in plasma cholesterol, a 
decrease of HMGR activity in both liver and intestine, an 
increase of acyl-CoA;cholesterol acyltransferase (ACAT) 
activity in liver and no change in intestine, and an 
increase in n-3 polyunsaturated fatty acids and a decrease 
in cholesterol in liver microsomes (Field et al., 1987). It 
was concluded that dietary manipulation caused changes in 
membrane fatty acid saturation in liver and intestine which 
changed HMGR and ACAT activities. 
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A special strain of rabbits called the Watanabe 
heritable hyperlipidemic (WHHL) rabbit has been the focus of 
many studies as an animal model to investigate the genetic 
defect of familial hypercholesterolemia (FH) in the human. 
Like FH patients, the WHHL rabbit has hypercholesterolemia 
despite the ingestion of a cholesterol-free diet, has 
elevation in LDL-cholesterol and develops atherosclerosis. 
It is now known that the WHHL rabbit has a single gene 
defect in the LDL receptor which results in inefficient 
removal of LDL from the blood and leads to 
hypercholesterolemia (Goldstein et al., 1983). Tissue 
culture studies using human skin fibroblasts showed that the 
same gene is defective in FH patients. 
Rat 
The rat is rather resistant to hypercholesterolemia and 
atherosclerosis. In order to produce hypercholesterolemia 
in the rat, people often use antithyroid drugs, female sex 
hormone (estradiol), bile acid (cholic acid) in addition to 
dietary cholesterol, or induction of essential fatty acid 
deficiency plus cholesterol supplementation. However, these 
treatments can cause some side effects such as 
hypothyroidism, sex hormone imbalance, etc. So, not much 
research has been done using hypercholesterolemic rats. 
Huang et al. (1986) induced hypercholesterolemia in rats and 
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investigated the effects of dietary fats. They found that 
polyunsaturated fat was more effective than saturated fat in 
lowering both plasma and liver cholesterol, and the 
reduction of saturated and monounsaturated fatty acids in 
plasma and liver cholesteryl esters was correlated with the 
reduction of plasma and liver cholesterol. Sugano et al. 
(1986) compared the hypocholesterolemic effects of evening 
primrose oil (linoleic plus 7-linolenic acids), safflower 
oil (linoleic acid) and olive oil (low linoleic acid) in 
hypercholesterolemic rats induced by feeding cholic acid and 
cholesterol. They found that the order of cholesterol 
lowering was: evening primrose oil > safflower oil > olive 
oil. 
More research was done using normocholesterolemic rats. 
The LDL to HDL ratio was lower when a low-fat diet (10 wt%) 
was fed than when a high-fat diet (25 wt%) was fed, and the 
ratio was lower when corn oil was the fat in the diet than 
when peanut oil was the fat source (Worthington and Miller, 
1986). Replacing sucrose by sunflower oil (Haug et al., 
1985) or increasing the polyunsaturated to saturated fatty 
acid ratio (P/S ratio) (Lim et al., 1985) in the diet 
lowered plasma cholesterol as well as HDL-cholesterol. 
Cholesterol-lowering was accompanied by an increase in fecal 
cholesterol excretion and ACAT activity. Cholesterol 
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synthesis was reported to be higher in rats fed corn oil 
than those fed beef tallow or low fat diets (Dupont, 1966). 
Studies on the lipoprotein profiles in normal and 
streptozotocin-induced diabetic rats (Hennig and Dupont, 
1983) suggested that excess intake of a diet high in 
saturated fat might induce a metabolic pattern similar to a 
diabetic state. The metabolic changes might be due in part 
to enzyme changes resulting from membrane lipid environment 
changes induced by diet. An increase in dietary linoleic 
acid was found to cause an increase in linoleic acid and a 
decrease in cholesterol content in hepatic plasma membranes 
and a suppression of glucagon-stimulated adenylate cyclase 
activity (Marson and Clandinin, 1985). 
Mouse 
Members of an inbred strain of mice of the same sex are 
more than 99.44% homozygous for the same genome or 
combination of gene pairs (Russell, 1969). As mice present 
a variety of inbred strains, they are useful in genetic 
experimentation. Mice exhibited marked strain differences 
in plasma cholesterol levels (Weibust, 1973; Yamamoto et 
al., 1963). Genetic factors governing the plasma 
cholesterol concentration in mice were polygenic and 
additive (Yamamoto et al,, 1963). The mode of inheritance 
was neither dominant nor recessive, but was intermediate 
(Bruell, 1963). 
25 
Inbred strains of mice also differed in their responses 
to diet in terms of blood cholesterol and in susceptibility 
to atherosclerosis. Roberts and Thompson (1975) screened 13 
strains of male inbred mice by feeding them either a regular 
laboratory diet or an atherogenic diet (a high-fat, high-
cholesterol diet containing 30 wt% cocoa butter, 5 wt% 
cholesterol and 30 wt% protein in the form of casein). Mice 
showed marked differences in plasma cholesterol 
concentrations and extent of atherosclerotic lesions. The 
C57BR/cdJ strain had the highest response (highest plasma 
cholesterol level and largest lesions with many foam cells) 
while the CBA/J strain had the smallest response. After 
crossing the most susceptible strain, C57BR/cdJ, with the 
least susceptible strain, CBA/J, these investigators 
concluded that atherosclerosis susceptibility and plasma 
cholesterol level showed polygenic inheritance (Roberts and 
Thompson, 1977). 
Paigen et al. (1985) fed ten strains of inbred mice an 
atherogenic diet containing 1.25 wt% cholesterol, 0.5 wt% 
cholic acid and 15 wt% fat. They confirmed Roberts and 
Thompson's work showing that inbred strains of mice differed 
in plasma cholesterol response to diet and in susceptibility 
to lesion formation. Aubert et al. (1987) also demonstrated 
genetic variations of blood cholesterol in inbred mice in 
26 
response to a hypercholesterolemia diet. However, there 
were inconsistencies among the reports. Aubert et al. 
(1987) did not find the CBA mouse a resistant strain to 
diet-induced hypercholesterolemia as did Roberts and 
Thompson (1975 and 1977), and they reported that DBA/2 mice 
had the lowest increase of serum cholesterol level when fed 
a hypercholesterolemic diet whereas Paigen et al. (1985) 
found that the same strain had the highest increase. Walker 
(1984) fed male CBA/J and C57BR/cdJ mice purified diets 
containing 10 wt% fat from different sources (sunflower oil, 
lard, olive-sunflower oil 77:23, or hydrogenated soybean-
sunflower oil 73:27). The CBA/J strain was more resistant 
while C57BR/cdJ mice were more susceptible to diet-induced 
plasma cholesterol changes, further confirming Roberts and 
Thompson's work. 
A similar conclusion was drawn by Morrisett et al. 
(1982). In addition, they found that on an atherogenic 
diet, CBA/J mice had a higher apo E/total lipoprotein ratio, 
and lower levels of VLDL and LDL than C57BR/cdJ mice. They 
then concluded that genetic resistance to diet-induced 
aortic atherosclerosis in mice was correlated with capacity 
to prevent large increases in serum cholesterol, to suppress 
abnormal a- and pre-/3 migrating lipoproteins, and to 
maintain an elevated serum apo E/total lipoprotein ratio. 
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Breckenridge et al. (1985) also investigated the lipoprotein 
profiles in these two strains of mice and got similar 
findings. Furthermore, they showed that the 
phosphatidylcholine/free cholesterol ratio of the VLDL, 
intermediate density lipoprotein (IDL) and LDL in C57BR/cdJ 
mice fed an atherogenic diet was noticeably lower than that 
of CBA/J mice; both strains fed the atherogenic diet had a 
marked decrease in the HDL fraction, but a greater reduction 
was seen in the C57BR/cdJ strain. Based on these findings, 
the investigators concluded that the development of 
atherosclerosis in C57BR/cdJ mice resulted from a greatly 
increased accumulation of cholesteryl ester-rich VLDL and 
IDL and a depletion of HDL, all of which were characterized 
by decreased phosphatidylcholine/free cholesterol ratio when 
compared to CBA/J mice. 
Regulation of Cholesterol Balance 
Cholesterol is present in all human tissues as free 
cholesterol and cholesteryl esters. Free cholesterol 
concentrations range from 0.9 mg/g of skeletal muscle to 3.9 
mg/g of adrenal gland. In adrenal gland, the ester form is 
approximately 83% of the total, and, in serum, the ester 
form is about 70%. Adipose tissue is a major cholesterol 
storage organ. It contains 0.6 - 1.6 mg of cholesterol per 
gram wet weight (Oh, 1982). 
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No enzymes in the body are capable of degrading the 
sterol nucleus of the cholesterol molecule. Since it would 
be detrimental to accumulate cholesterol within the body, it 
is important that the rate at which the body acquires 
cholesterol from all sources must be essentially balanced by 
the rate at which the body can excrete the sterol molecule. 
Cholesterol enters the body pool from two sources. It may 
be absorbed from the diet (300-500 mg/day in man) or 
synthesized within the various organs (700-900 mg/day in 
man). There are also two mechanisms for removal of 
cholesterol from the body. Either cholesterol itself is 
excreted into the gastrointestinal tract (approximately 600 
mg/day), or is lost through the sloughing of skin 
(approximately 85 mg/day), or the cholesterol is first 
converted to bile acids (approximately 400 mg/day) or 
steroid hormones (approximately 50 mg/day) which, in turn, 
are excreted from the body in bile or urine. During the 
active growth phase, some cholesterol (approximately 1.5 g 
cholesterol/Kg body weight gained) is used to build new body 
tissue (Dietschy, 1984). To maintain this critically 
important balance of cholesterol across the body and to 
ensure adequate supplies of cholesterol to all major organs, 
elaborate regulatory and transport mechanisms have evolved. 
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Cholesterol synthesis 
The overall rate of cholesterol synthesis is determined 
by the activity of hydroxymethylglutaryl coenzyme A 
reductase (HMGR) which catalyzes the reductive deacylation 
of hydroxymethylglutaryl coenzyme A (HMG-CoA) to mevalonate 
by two molecules of NADPH. HMGR has been detected in many 
species and probably is present in any life form capable of 
synthesizing isoprenoids. In mammals, HMGR activity has 
been detected in many tissues and is associated almost 
exclusively with the microsomal membrane fraction except 
adrenal gland in which a major fraction is associated with 
mitochondria (Gill et al., 1985). 
Cholesterol synthesis and HMGR activity vary with the 
physiological states of the organism. For instance, 
cholesterol feeding and fasting decrease while 
cholestyramine feeding increase the enzyme activity and 
cholesterol synthesis in the liver. Also, HMGR activity and 
cholesterol synthesis showed similar patterns of diurnal 
variations and developmental changes (Gill et al., 1985). 
In vitro studies with human skin fibroblasts and leukocytes 
showed that HMGR and cholesterol synthesis were depressed by 
the addition of serum and derepressed by the removal of 
serum (Avigan et al., 1970; Brown et al., 1973; Fogelman et 
al., 1975). This serum factor was found to be LDL. A 
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receptor-mediated pathway was postulated by Brown and 
Goldstein (1986) to explain cholesterol homeostasis. 
Four mechanisms have been proposed to describe the 
regulation of HMGR activity. These include interconversion 
of active and inactive forms by dephosphorylation-
phosphorylation, modulation by membrane fluidity, changes in 
enzyme synthesis rate or changes in enzyme degradation rate. 
It is possible that different types of cells exhibit 
different mechanisms or that several mechanisms operate in 
the same cell. Tissues such as liver and steroid-secreting 
organs, which may have sudden demands for large amounts of 
cholesterol, may use the phosphorylation-dephosphorylation 
mechanism to maintain a reservoir of inactive HMGR that can 
be quickly activated. On the other hand, tissues that have 
lower and more constant demands for sterol, such as cultured 
fibroblasts, may not need such a mechanism for short term 
control and use enzyme synthesis and degradation mechanisms 
instead (Brown et al., 1979). 
Cellular uptake of cholesterol 
Brown and Goldstein (1986) used human skin fibroblasts 
as a cultured cell model to investigate the regulation of 
cholesterol homeostasis. They discovered a receptor-
mediated pathway for cholesterol uptake called the LDL 
pathway. The LDL pathway consists of an ordered sequence of 
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events. First, LDL is bound to a high-affinity receptor on 
the cell surface. Through the clustering of LDL receptors 
in coated pits, LDL receptors are internalized by 
endocytosis. The receptors dissociate from LDL after 
internalization and recycle back to the surface. LDL is 
delivered to lysosomes where the cholesteryl esters are 
hydrolyzed resulting in the release of free cholesterol. 
The cholesterol (or an oxygenated derivative that is formed 
within the cell) is responsible for at least three metabolic 
controls; 1) it acts at several levels to reduce the 
activity of HMGR, including suppression of transcription of 
the HMGR gene and acceleration of the degradation of the 
enzyme protein, thus decreasing the rate of cellular 
cholesterolgenesis; 2) it activates ACAT, thus increasing 
the rate of cellular esterification; and 3) it suppresses 
synthesis of LDL receptors by lowering the concentration of 
LDL receptor messenger RNA (mRNA), By receptor regulation, 
the cells adjust to provide sufficient cholesterol for 
metabolic needs without causing cholesterol 
overaccumulation. The LDL receptor recognizes apo E when it 
is present together with apo B-lOO or apo B-48, or apo B-lOO 
alone. So, it binds endogenous lipoproteins (IDL and LDL) 
as well as exogenous lipoproteins (chylomicron remnants). 
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A different receptor, mediating the cellular uptake of 
the cholesterol-containing lipoproteins, called chylomicron 
remnant receptor has been described by Brown and Goldstein 
(1983). This receptor exists predominantly on hepatocytes. 
It recognizes apo E when it is present on a chylomicron 
remnant, but not when it is associated with apo B-lOO, This 
receptor mediates the uptake of lipoproteins that carry 
exogenous cholesterol, i.e., chylomicron remnants. 
With constant infusion techniques and LDL preparations 
labeled with markers, Spady et al. (1983) quantitated the 
rates of LDL uptake and the proportion using the receptor-
dependent process by different organs in the hamster. 
Approximately 75% of LDL turnover from the plasma 
compartment is accounted for by uptake into the liver. The 
small intestine accounts for 7% and the remaining organs 
account for only trivial amounts. However, the highest rate 
of uptake on a weight basis was seen in the adrenal gland. 
In the liver, ovary, and kidney, the vast majority of LDL 
uptake is by the receptor-mediated process, while in the 
spleen and intestine, receptor-independent LDL transport is 
relatively more important. As approximately 75% of 
circulating LDL is cleared by the liver and more than 90% of 
this clearance is mediated through the LDL receptor 
mechanism, the plasma LDL-cholesterol level will be very 
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sensitive to the number of LDL receptors present on the 
sinusoidal membrane of the liver cell (Dietschy, 1984). 
Catabolism and excretion 
Cholesterol cannot be broken down by oxidation to 
carbon dioxide and water, because mammalian tissues do not 
have enzymes capable of catabolizing the steroid nucleus. 
Cholesterol is mainly excreted into feces either as neutral 
sterols or bile acids. 
The neutral sterols represent a mixture of endogenous 
cholesterol and its derivatives and unabsorbed dietary 
sterols of animal and vegetable origin. They are delivered 
to the intestine from the liver in the bile, through the 
sloughing of intestinal mucosal cells or from the diet. 
Some cholesterol in the intestinal tract is acted on by 
intestinal bacterial enzymes and converted to other neutral 
sterols before excretion in the feces. In humans the main 
neutral sterol products in the stool are coprostanol and 
cholestanone. Cholestanol is another metabolic product of 
cholesterol that is formed in the liver and delivered into 
the intestine in the bile. 
Bile acids are hydroxyl derivatives of cholanic acids, 
a 24-carboxyl compound of the parent hydrocarbons, 5a- and 
5/3-cholane. Primary bile acids are synthesized de novo from 
cholesterol in the liver, including cholic acid and 
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chenodeoxycholic acid whereas secondary bile acids are 
formed from primary bile acids by intestinal microorganisms 
through deconjugation, dehydroxylation and reduction. The 
main secondary bile acids in humans are deoxycholic acid and 
lithocholic acid. Bile acids formed in the liver are 
conjugated at C24 with either glycine or taurine before 
being secreted into the bile. In most vertebrates, bile is 
continuously produced by the liver and stored in the gall 
bladder. When food enters the duodenum, cholecystokinin-
pancreozymin is released; this facilitates the contraction 
and emptying of the gallbladder, and the bile, containing 
bile salts, enters the lumen of the small intestine via the 
common bile duct. Most of the bile acids excreted into the 
gastrointestinal tract are reabsorbed rapidly in the ileum 
by active transport or passive ionic and nonionic diffusion. 
Under normal conditions, about 95% of the bile acids are 
absorbed, and the rest are excreted via the feces. This 
process of recycling is called the enterohepatic 
circulation. 
Bile acids are formed from cholesterol by 
hydroxylation, reduction and side chain cleavage. The first 
and the rate-limiting step is the insertion of a hydroxyl 
group at position C7, which is catalyzed by cholesterol 
7a-hydroxylase (COH). COH is a microsomal enzyme requiring 
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cytochrome P450, NADPH, O2 and succinate as a respiratory 
substrate. Its activity and thus bile acid biosynthesis are 
regulated by the amount of bile acids that are reabsorbed 
through enterohepatic circulation. In addition to being a 
catabolite and excretory product of cholesterol, bile acids 
also play some active roles such as facilitating the 
absorption of fat and fat-soluble vitamins by dispersing and 
solubilizing dietary fats and interacting with pancreatic 
lipase-colipase (Goswami and Dupont, 1982). 
Cholesterol kinetics 
Whole body cholesterol metabolism has been customarily 
studied by following the decline of plasma cholesterol 
specific activity over time after a single injection of 
tracer. Each change of slope of the curve is interpreted as 
indicating a different kinetic pool of cholesterol. In 
other words, the pools represent tissues having different 
rates of equilibrium of cholesterol with serum cholesterol. 
By such a curve-peeling technique, Goodman et al. (1973) 
described three kinetic pools of cholesterol in humans — a 
rapidly miscible pool, a slowly miscible pool and a very 
slowly miscible pool. Studies of tissue cholesterol 
metabolism (Dupont, 1982) suggested that the rapidly 
miscible pool contained cholesterol in the liver, plasma, 
red blood cells and intestine; the slowly miscible pool 
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contained muscle and adipose cholesterol; and the very 
slowly miscible pool contained cholesterol of brain and 
nervous tissue. 
Dietary Recommendations 
Epidemiology and human and animal experimentations all 
suggest that diet can affect blood cholesterol, and blood 
cholesterol level has a causal relationship to 
atherosclerosis. There is no evidence that a moderate-fat, 
low-cholesterol diet is harmful. Considering the high 
prevalence of heart problems in the United States, a 
consensus development committee of the National Heart, Lung 
and Blood Institute and the National Institutes of Health 
recommended to all Americans a shift from the current 
average American diet to one that is lower in total fat, 
saturated fat and cholesterol — reduction of calories from 
fat to 30%, calories from saturated fat to 10% or less, and 
dietary cholesterol to no more than 250 to 300 mg daily, and 
an increase of calories from polyunsaturated fat, but to no 
more than 10% of total calories (Consensus Conference, 
1985). This diet is consistent with the earlier 
recommendations of the American Heart Association (AHA 
Committee Report, 1978). 
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Reaven (1986) challenged the recommendations of the 
consensus conference (1985) and questioned whether all 
Americans can benefit from the moderate-fat, high-
carbohydrate diet. He suspected that such modifications 
would actually increase the risk of developing heart disease 
in some individuals such as carbohydrate-intolerant people. 
There are still some uncertainties about the dietary 
recommendations. Since individual variation in response to 
diet is great, should recommendations be different for 
responders and nonresponders? Polyunsaturated fats decrease 
HDL-cholesterol as well as LDL and may cause some health 
problems such as gallstones; there is some suspicion of 
cancer also. How much polyunsaturated fat is safe but 
sufficient to protect people from heart disease? The 
present dietary recommendations are the best based on 
available information. However, more research is needed to 
resolve the uncertainties and give even better 
recommendations to the public and to individuals. 
Purpose of the Study 
This study was designed to investigate the effects of 
genetics and diets on cholesterol metabolism in mice. Mice 
are small and economic laboratory animals. Furthermore, the 
availability of different inbred strains facilitates genetic 
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experimentation. The first study tested whether mice 
responded to dietary pectin or fat manipulation and whether 
there were sex, light and genetic differences in the 
response using hepatic hydroxymethylglutaryl coenzyme A 
reductase activity as an index. The second and the third 
studies investigated the effects of dietary fat 
modifications on cholesterol metabolism in C57BR/cdJ and 
CBA/J mice. The C57BR/cdJ strain was reported as a 
hyperresponder to diet-induced hypercholesterolemia and 
susceptible to atherosclerosis, while the CBA/J strain was 
considered a hyporesponder and resistant to atherosclerosis. 
The dietary manipulations included a diet high in total fat 
and cholesterol and low in P/S ratio like the average 
American diet in 1974, and one moderate in total fat and 
cholesterol but high in P/S ratio close to the US Dietary 
Goals. 
Explanation of Thesis Format 
This thesis is composed of three papers. The first 
paper reports hepatic hydroxymethylglutaryl coenzyme A 
reductase activity in inbred strains of mice. The second 
and third papers report the effects of dietary fat on static 
metabolic measurements and whole body cholesterol kinetics, 
respectively, in mice genetically susceptible and resistant 
to atherosclerosis. 
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Dr. Jacqueline Dupont supervised all three studies. 
For the first paper, the Ph.D. candidate, Son-iu Kuan, with 
the assistance of David A. Warner, fed C57BL/6J mice, made 
diets, killed mice, prepared liver microsomes and performed 
all hydroxymethylglutaryl coenzyme A reductase assays 
including those of microsomes shipped from the Paris 
collaborators. Son-iu Kuan also did the whole set of 
experiments on CBA/J mice and all the statistical analyses. 
For the second paper, Son-iu Kuan designed and performed the 
entire study. For the third paper, Son-iu Kuan did the 
laboratory work, and Dr. Richard Seagrave and Leah Patterson 
helped with data analysis and mathematical modeling. 
Additional methodological testing with the help of Dr. Henry 
Stahr is reported in the general discussion. 
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PART 1. HEPATIC HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE 
ACTIVITY IN INBRED STRAINS OF MICE 
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ABSTRACT 
Hydroxymethylglutaryl coenzyme A reductase (HMGR) 
activity is a major factor in regulation of cholesterol 
homeostasis. The enzyme activity is known to vary with age, 
sex, diurnal cycle and dietary properties in rats. Mice are 
available in numerous genetic strains and could be a useful 
inexpensive animal model for studying diet and genetic 
interactions in regulation of cholesterol metabolism. Obese 
and nonobese C57BL/6J, CBA/J and obese and nonobese DW db^®® 
mice were subjected to variations in light cycle, feeding 
schedule and pectin and fat composition of their diets. 
They were then killed by decapitation and hepatic microsomal 
HMGR analyzed. The mice responded to light cycle, feeding 
pattern and sex difference. They exhibited marked 
differences due to age, genotype, strain and diet 
variations. We conclude that they will, indeed, offer an 
excellent animal model for the study of regulation of 
cholesterol metabolism. 
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INTRODUCTION 
Hydroxymethylglutaryl coenzyme A reductase (HMGR, 
EC.1.1.34) activity is well known to vary with age (Shefer 
et al., 1972), sex (Carlson et al., 1978) and diurnal cycle 
(Shefer et al., 1972; Carlson et al., 1978). Many factors 
in the diet including plant fiber (Eastwood and Kay, 1979) 
and type of fat (Faas et al., 1978) also act to influence 
HMGR activity. These results have been observed with rats 
as well as with some other species. Little has been 
reported regarding HMGR activity in the mouse. Energy 
metabolism is also an effector of regulation of cholesterol 
metabolism (Dupont, 1987), but studies of cholesterol 
metabolism in relation to energy usage have not been 
included in characterization of differences between 
genetically different animals. The following studies have 
been conducted to evaluate the value of use of genetically 
diverse strains of mice as models for studying cholesterol 
metabolism. 
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METHODS 
Animals 
Genetically obese (C57BL/6J) mice and nonobese 
littermates were bred in the ISU Food and Nutrition 
Department colonies. They were maintained at 24±3°C with 
twelve hour cycles of light from 0700 to 1900 and darkness 
from 1900 to 0700 h. During breeding, gestation and 
lactation, the mice were fed a commercial stock diet (Purina 
Rat Chow, Ralston Purina Co., St. Louis, MO) and had 
unlimited access to the food and to tap water. Genotype of 
the ob/ob mice was determined as described by Fanelli and 
Kaplan (1978). At weaning the mice were segregated by sex 
and genotype and caged in groups until used for this 
experiment. 
At about 8-9 wk of age C57BL/6J mice were put into a 
room with normal (light 0600-1800 h) or a reversed light 
cycle (light 1800-0600 h) and placed on a purified control 
or high pectin diet at about 10 wk of age. After 15-18 d of 
consumption of the purified diets they were killed by 
decapitation at 1000-1100 h, livers were excised and 
microsomes were isolated for HMGR assay. 
Six-wk-old male CBA/J mice were purchased from the 
Jackson Laboratory (Maine). They were kept in a reversed 
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light room (light 1700-0500 h) and fed a diet (US74) 
corresponding to the average consumption in the U.S.A. in 
1974 or a modified fat diet formulated to contain 10% of 
linoleate and 10% of saturated fat. After 4 wk of feeding, 
some mice were killed at their mid-dark cycle (1000-1100 h). 
Blood was collected, livers were excised and liver 
microsomes were prepared. Serum and liver microsomes were 
frozen at -80°C for later analysis. The remaining mice were 
switched to the other diet, i.e., those fed US74 diet were 
changed to modified diet and vice versa (crossover). After 
another 4 wk, mice were killed and serum and liver 
microsomes were prepared. 
Genetically obese DW db^®® (Aubert et al., 1985) mice 
were grown at the U.l INSERM, Hôpital Bichat, Paris. They 
were maintained at 22+l°C with a regulated light cycle 
corresponding to normal light and dark. They were caged in 
groups segregated by sex and genotype. They had unlimited 
access to food and water. At age 12 or 24 mo they were 
subjected to a schedule of removal of food at 1800 h and 
replacement at 0730 h for 2 d. On the second day they were 
killed by decapitation at 1100-1200 h. This schedule is 
analogous to the habit of food consumption when rodents 
enter the dark cycle, that is, approximately 4 h into the 
period of normal food consumption. 
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Experimental Diets 
The C57BL/6J and CBA/J mice were caged singly and fed a 
purified diet based upon that devised by Fanelli and Kaplan 
(1978) with variation in fiber intake by manipulation of 
pectin or variation of fat composition. For evaluation of 
the effect of dietary fiber the diets were isocaloric (Table 
1) with replacement of fat by pectin for the control and 
high pectin diets. The diets used to compare fat 
composition were isonutrient (Kuan and Dupont, 1987). The 
diets were pelleted and provided fresh at 3-d intervals. 
Food intake was determined for the comparison of high and 
low pectin diets in the C57BL/6J mice. 
Serum Cholesterol Determination 
Very low density and low density lipoproteins were 
precipitated by HDL precipitating reagent purchased from 
Sigma (St. Louis, MO). The serum total and HDL-cholesterol 
were determined using the enzymatic reagent kit from Sigma. 
Hydroxymethylglutaryl CoA Reductase Assay 
Microsomes were isolated from excised livers which were 
held on ice (4°C) throughout the procedure. The liver was 
minced, homogenized in a Potter-Elvehjem tissue grinder with 
teflon pestle with 4 volumes of potassium phosphate (KPi) 
; 
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TABLE 1. Composition of control and high pectin diets 
ingredient control high pectin 
casein 20 
DL-methionine 0.3 
minerals 5.0 
vitamins 1.0 
choline chloride 0.2 
beef tallow 16,5 
corn oil 4.5 
sucrose 24 
corn starch 20 
dextrin 5 
cellulose 3.5 
pectin 0 
Kcal 
80 
148.5 
40.5 
96 
80 
20  
20 
0.3 
5.0 
1.0 
0.2 
26.5 
4.5 
13 
11 
2.5 
3.5 
12.5 
Kcal 
8 0  
238.5 
40.5 
52 
44 
10 
total 100 465 100 465 
48 
buffer and centrifuged at 20,000 x g for 30 min. The 
supernatant was transferred to a tube for centrifugation at 
100,000 X g in a 50 Ti rotor for 60 min. The pellet was 
resuspended using a Kontes tube and hand-operated pestle in 
the same buffer and stored at -80°C. Samples prepared in 
Paris were transferred to Iowa stored in dry ice. HMGR 
activity was determined in the samples from both 
laboratories with a random distribution of treatments. The 
methods of Nordstrom et al. (1977) were used. The Lowry 
method as modified by Peterson (1977) was used to determine 
microsomal protein. 
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RESULTS 
Body and liver weights of the mice used in the feeding 
experiments and their food intakes are shown in Table 2. 
HMGR activities of C57BL/6J mouse liver microsomes are shown 
in Table 3. The comparison of environment (light vs. dark) 
was made only in female mice fed the control diet. There 
was a significantly greater HMGR activity at 5 h into the 
dark cycle for the mice when the activity was expressed as 
nmoles mevalonate formed per milligram of microsomal 
protein. The obese mice had significantly less HMGR 
activity than did their lean littermates, and their response 
to the environmental change was less marked which resulted 
in a significant interaction of time vs. genotype. The 
genotype effect was entirely caused by difference in liver 
size as indicated by disappearance of the difference when 
the values were calculated for the total liver. The enzyme 
activity differences were analogous when expressed per 
milligram of protein and per gram of body weight. 
Males were compared with females only in the dark cycle 
and with the control diet. There was no difference caused 
by sex in the lean mice, but the obese males had 
significantly greater HMGR activity than obese females. The 
diet effect was studied only in males in the dark cycle. 
There was a significantly elevated HMGR activity with the 
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TABLE 2. Body and liver weights of C57BL/6J, CBA/J, and DW 
db^®® mice (n=3-8 per group) 
body liver food 
strain diet weight weight intake 
g/day 
C57BL/6J, male 
lean control 27.3 
lean pectin 25.2 
obese control 49.0 
obese pectin 43.3 
SEM 2.39 
1.14' 
1.22 
3.30 
1.91 
0.20 
1.77' 
2.11 
2.63 
3.08 
0.15 
CBA/J, male 
4 wk US74 
4 wk modified 
8 wk US74 
8 wk modified 
SEM 
Pas DW db 
lean 
obese 
SEM 
1 yr, male 
42.9^ 
35.8 
44.8 
43.4 
1.02 
36.6* 
76.8 
2.37' 
1.76 
2.18 
1.91 
0.09 
1.67' 
2.27 
^Significant effects of diet (P<0,01), genotype 
(P<0.01) and diet x genotype interaction (P<0.01). 
^Significant effects of genotype (P<0.01) and diet 
(P<0.05). 
^Significant effects of age (P<0.01) and diet (P<0.05). 
^Significant effect of diet (P<0.05). 
^Significant effect of genotype (P<0.05). 
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TABLE 3. Hydroxymethylglutaryl CoA reductase activity in 
obese and nonobese C57BL/6J mice (n=6 per group) 
sex time genotype diet HMGR 
per mg per 
protein liver 
nmoles mevalonate formed 
F light lean control 0.80® 9.4 
F light obese control 0.44 11.9 
F dark lean control 2.43 25.9 
F dark obese control 0.76 20.3 
SEM 0.21 4.3 
M dark lean control 2.89 41.9 
M dark obese control 1.44 41.4 
M dark lean pectin 5.00 99.7 
M dark obese pectin 3.65 90.9 
SEM 0.46 15.6 
Significant effects of sex 
genotype (P<0.01), diet (P<0.01) 
interaction (P<0.05). 
^Significant effects of sex 
diet (P<0.01). 
(P<0.05), time (P<0.01), 
and time by genotype 
(P<0.01), time (P<0.01) and 
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high pectin diet as compared to the control diet in both 
lean and obese mice. The effect of genotype was related to 
liver size and the genotype difference was lost when the 
activity of the whole liver was calculated. 
Serum cholesterol concentrations and liver microsomal 
HMGR activity of male CBA/J mice are shown in Table 4. Diet 
did not affect either total or HDL cholesterol 
concentration. The enzyme activity was extremely responsive 
to dietary fat. The diet higher in total and saturated fat 
(US74) inhibited HMGR activity by 86% compared to the diet 
modified to contain 30% total fat with 10% saturated and 10% 
linoleate. The effect was partially due to differences in 
liver size in the younger group and the older mice had lower 
activity than did the younger group. 
In the DW db^^® mice genotype difference was studied 
only in males. There was a genotype difference in HMGR 
activity (Table 5) expressed per milligram of microsomal 
protein (P<0.05). The difference was enhanced when the 
enzyme activity was expressed as activity per liver in the 
2-yr-old mice and diminished, but was not eliminated per 
liver in the 1-yr-old mice. These results are contrary to 
those observed in C57BL/6J mice. The two strains were not 
observed in the same experimental conditions. The 
comparison between the male C57BL/6J mice fed control diet 
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TABLE 4. Serum cholesterol and HMGR activity in liver 
microsomes of CBA/J male mice (n=3-8 per group) 
period diet HMGR serum cholesterol 
per mg per 
protein liver total HDL 
4 wk US74 
4 wk modified 
8 wk US74 
8 wk modified 
SEM 
nmoles mevalonate 
formed 
0.33® 9.06® 
2.37 40.2 
0.16 3.55 
1.33 24.9 
0.19 3.28 
mg/dl 
181 104 
154 100 
163 101 
146 96 
5.40 2.70 
^Significant effects of age (P<0.01) and diet (P<0.01). 
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in the dark cycle and the younger male db^®® mice is most 
analogous. The genotypic results for HMGR activity are 
opposite in this comparison, C57BL/6J being greater for the 
lean and db^^® greater for the obese. 
The differences in enzyme activity in the 2-yr-old 
dbPas mice were not associated with differences in lipid 
composition of the livers (Table 6). No statistical 
differences in cholesterol, triglyceride or phospholipid 
concentration in the liver were observed. 
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TABLE 5. Hydroxymethylglutaryl CoA reductase activity in 
liver microsomes of male DW db^^® mice {n=3-6 per 
group) 
genotype 
1-yr-old mice 
per mg per 
protein liver 
HMGR® 
2-yr-old mice 
per mg per 
protein liver 
n moles mevalonate formed 
lean 2.73 31.5 1.68 16.4 
obese 0.25 5.2 3.50 42.0 
SEM 0.33 3.6 0.29 3.8 
^Significant effects of genotype (P<0.01). 
56 
TABLE 6. Lipid composition of liver of 2-yr-old male DW 
db^®® mice 
lipid lean (n=5) obese (n=3) SEM 
mg/g liver 
cholesterol 2.01 2.18 0.20 
triglycerides 19.15 18.23 2.48 
phospholipids 22.59 19.00 1.38 
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DISCUSSION 
Mice responded to the factors which influence HMGR 
activity in rats in the same ways. Sex differences exist as 
reported for rats (Carlson et al., 1978), and there is a 
clear diurnal variation as reported for rats (Carlson et 
al., 1978; Shefer et al., 1972). As in rats (Mueller et 
al., 1983) increasing dietary pectin increased HMGR 
activity. Diets high in linoleate resulted in higher HMGR 
activity than did diets with high saturated fat as reported 
for rats (Faas et al., 1978). The results are analogous to 
reported effects in rats of such diets on cholesterol 
synthesis from acetate (Dupont, 1965). A decline in 
cholesterol synthesis with maturation also has been reported 
in rats (Story et al., 1976). Few observations have been 
made of old rats, but there may be a decrease in cholesterol 
synthesis after age 18 mo (Dupont et al., 1978). Obese 
db^^® mice are also hypercholesterolemic (Aubert et al., 
1985). The CBA/J mice have been reported to be resistant to 
development of atherosclerotic lesions when fed a high-fat, 
high-cholesterol diet (Paigen et al., 1985). Their ability 
to modify cholesterol synthesis with even a small change in 
dietary fat may be indicative of a general ability to adapt 
cholesterol metabolism to diet to maintain homeostasis. 
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These several strains of mice offer models for the 
study of the interaction between genetics and dietary 
factors in regulation of lipid metabolism. They may also 
provide a suitable model to identify the metabolic stresses 
which result in development of atherosclerosis. 
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PART 2. DIETARY FAT EFFECTS ON CHOLESTEROL METABOLISM IN 
CBA/J AND C57BR/CDJ MICE 
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ABSTRACT 
The aim of this study was to determine how small 
differences in dietary fats affect cholesterol metabolism in 
mice hypo- and hyperresponsive to diet-induced 
hypercholesterolemia. Six-wk-old male hyperresponders 
(C57BR/cdJ mice) and hyporesponders (CBA/J mice) were fed 
either a US74 diet (40 en% as fat, 347 mg cholesterol / 1000 
Kcal, P/S=0.24) or a modified fat diet (30 en% as fat, 46 mg 
cholesterol / 1000 Kcal, P/S=0.91). After 8 wk of feeding, 
neither strain developed hypercholesterolemia. CBA/J mice 
had higher serum total, HDL, and esterified cholesterol 
concentrations than did C57BR/cdJ mice. CBA/J mice showed 
marked differences in responses to dietary fat compared with 
C57BR/cdJ mice. CBA/J mice responded to the US74 diet by 
decreasing the hepatic synthesis of cholesterol as a result 
of suppression of hydroxymethylglutaryl coenzyme A reductase 
(HMGR) activity. C57BR/cdJ mice, on the other hand, 
responded to the US74 diet compared to the modified fat diet 
by increasing the fecal excretion of cholesterol. Compared 
to the modified fat diet, the US74 diet caused an increase 
in serum total to HDL cholesterol ratio, liver microsomal 
total and free cholesterol, and hepatic microsomal 
cholesterol 7a-hydroxylase activity in the CBA/J strain, and 
caused an increase in fecal cholesterol and a decrease in 
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fecal ergosterol and ^-sitosterol, and hepatic microsomal 
HMGR activity in both strains. We conclude that the 
metabolic responses to small differences in dietary fat are 
different in CBA/J and C57BR/cdJ mice and the genetic 
propensity to hypercholesterolemia of C57BR/cdJ mice is not 
expressed when they are young. 
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INTRODUCTION 
There is a wide variation among individuals in response 
to dietary fat — some individuals are especially 
susceptible (hyperresponders) to diet (high cholesterol, 
high saturated fat)-induced hypercholesterolemia while some 
are particularly resistant (hyporesponders) (Clarkson et 
al., 1985). Although this phenomenon has been known for 
some time, the underlying mechanisms are still unknown, 
probably because of the limitations of human 
experimentation. Moreover, the Dietary Goals for the United 
States (1977) suggest reducing average dietary fat to 30% of 
total energy, reducing cholesterol to 300 mg per day, and 
increasing the P/S ratio (polyunsaturated to saturated fatty 
acid) to 1.0. How this change will affect metabolism and 
how the metabolism differs between the hyper- and 
hyporesponders is not known. So, an appropriate animal 
model can be used to determine specific biochemical events. 
Roberts and Thompson (1975) screened 13 strains of 
inbred mice and found that the C57BR/cdJ strain was very 
susceptible to and the CBA/J strain was resistant to dietary 
cholesterol and saturated fat-induced hypercholesterolemia 
and atherosclerosis. Walker (1984) confirmed their results. 
Mulvihill and Walker (1984) further characterized C57BR/cdJ 
mice and found that the serum cholesterol concentration was 
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inversely related to the dietary P/S ratio. These phenomena 
are very similar to those which occur in humans (Clarkson et 
al., 1985). The C57BR/cdJ and CBA/J strains of mice, 
therefore, may be good animal models to study cholesterol 
metabolism as related to genetic differences in response to 
dietary fat manipulation. In this study, the effects of 
dietary fat on cholesterol metabolism in C57BR/cdJ and CBA/J 
mice were investigated. The diets compared were a diet high 
in total fat and cholesterol and low in P/S ratio like the 
average American diet in 1974, and one moderate in total fat 
and cholesterol and high in P/S ratio as suggested by the US 
Dietary Goals. 
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MATERIALS AND METHODS 
Experimental Design 
C57BR/cdJ (susceptible to diet-induced atherosclerosis) 
and CBA/J (resistant) were purchased from the Jackson 
Laboratory (Maine) and bred in the Animal Care Facility of 
the Food and Nutrition Department, Iowa State University. 
The breeders and the post-weaning offspring were fed Purina 
Breeder Chow. At 6 wk of age, male mice were caged singly 
in a room with a reversed light cycle (light: 1700-0500 h; 
dark: 0500-1700 h) and fed either a US74 or a modified fat 
diet (Table 7). There were 8 mice per treatment. The two 
experimental diets used were isonutrient and were based upon 
that devised by Fanelli and Kaplan (1978) with variations in 
fat composition. The dietary fat composition was calculated 
using the USDA Handbook No. 8-4 (Consumer and Food Economics 
Institute, 1979) and was similar in energy yielding 
nutrients to that of a human study done in our department 
(Batres-Cerezo et al., 1987; Garcia et al., 1987). The US74 
diet had a fat content and composition similar to that of 
the average American diet in 1974 in accord with the HANES I 
survey (Abraham and Carroll, 1979) (40% of energy from fat, 
600 mg cholesterol / 2000 Kcal, and a P/S ratio of 0.3), 
while the modified fat diet was designed to meet the Dietary 
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Goals for the United States (1977) (30% of energy from fat, 
less than 300 mg cholesterol / 2000 Kcal, and a P/S ratio of 
1.0). The feeding lasted for 8 wk. Feces excreted during 
the last three days of the dietary treatments were collected 
and frozen for later analysis of neutral sterols and bile 
acids. 
Diet Analyses 
The experimental diets, US74 and modified fat diets, 
were analyzed for fatty acid and neutral sterol 
compositions. An aliquot of the diet was ground and lipids 
were extracted with chloroform/methanol (2:1, v/v). The 
extract was saponified in 10% ethanolic KOH at 60°C for 1 
hour. Neutral sterols were extracted with petroleum ether, 
silylated with Sil-prep (Alltech-Applied Science) and 
analyzed by using a Beckman gas chromatograph equipped with 
a flame ionization detector and an 8 ft x 1/8 in OD, 2 mm ID 
glass column packed with 5% OV210, 80-100 mesh. Instrument 
settings were; column temperature 220°C, detector 
temperature 250°C, inlet temperature 260°C, and detector 
line temperature 270°C, and nitrogen flow 20 ml/min. 
Identification of trimethylsilyl (TMS) derivatives of 
neutral sterols was by comparison of their retention times 
with those of silylated standards. Quantitation was done by 
comparison with an internal standard, 5a-cholestane. 
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TABLE 7. Compositions of US74 and modified fat diets 
ingredient US74 modified 
g  Kcal 9  Kcal 
high nitrogen casein® 18.0 72.0 18.0 72.0 
DL-methionine® 0.3 0.3 
AIN76 mineral mixture^ 5.0 5.0 
AIN76 vitamin mixture^ 1.0 1.0 
choline chloride® 0.2 0.2 
beef tallow^ 16.2 145.8 7.2 64.8 
•  i d  
corn oil 3.3 29.7 7.3 65.7 
sucrose 22.0 88.0 27.0 108.0 
corn starch 20.0 80.0 25.0 100.0 
dextrin^ 4.25 17.0 5.5 22.0 
celufil® 3.48 3.48 
cholesterol® 0.132 0.012 
L-ascorbic acid^ 0.010 0.010 
total 93.872 432.5 100.002 432.5 
^Purchased from United States Biochemical Co., 
Cleveland, OH. 
^Purchased from ICN Biochemicals, Cleveland, OH. 
^Purchased from the Meat Lab., ISU, Ames, lA. 
^Mazola corn oil, Englewood Cliffs, NJ. 
^Purchased from Sigma Chemical Co., St. Louis, MO. 
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Table 7 (continued) 
ingredient US74 modified 
fat (%Kcal) 40.6 30.2 
S:M:pf 1.0:0.9:0.31 1.0:1.05:1.0 
cholesterol 347 46 
(mg/1000 Kcal) 
^Saturated: monounsaturated: polyunsaturated fatty 
acids. 
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The ethanolic fraction was acidified to pH<5 with 6 N 
HCl and fatty acids were extracted with petroleum ether. 
The fatty acids were methylated by heating with 
borontrifluoride/methanol (Alltech-Applied Science) for 2 
min in a boiling water bath. After the sample cooled, 
methylated fatty acids were extracted with hexane and 
separated by using a Beckman gas chromatograph equipped with 
a flame ionization detector and a 6 ft x 1/8 in stainless-
steel column packed with Altex Chrom WAW 10% CSIO, 100-120 
mesh. Instrument settings were; column temperature 180°C, 
detector temperature 250°C, inlet temperature 220°C, 
detector line temperature 250°C, and nitrogen flow 20 
ml/min. Identification of fatty acid methyl esters was by 
comparison of their retention times with those of known 
methylated standards. 
Tissue Analyses 
At the end of the feeding period, mice were 
anesthetized with ether and killed by decapitation at 
1000-1100 h. Blood was collected and allowed to clot at 
room temperature. Serum was prepared by centrifuging the 
blood at 2,000 x g for 10 min (Beckman Model J-6B 
centrifuge) and stored at -80°C until analysis. Livers were 
excised and microsomes were prepared (Angelin et al., 1982). 
Liver microsomes were stored at -80°C until analysis. 
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Serum 
Very low density lipoprotein (VLDL) and low density 
lipoprotein (LDL) were precipitated with sodium 
phosphotungstate and magnesium chloride (Seigler and Wu, 
1981) using a kit from Sigma Chemical Co. (St. Louis). The 
enzymatic method (Allain et al., 1974) was used to determine 
the total, free, and HDL-cholesterol in serum. 
Liver 
The activities of hydroxymethylglutaryl coenzyme A 
reductase (HMGR) and cholesterol 7a-hydroxylase (COH) in 
liver microsomes were determined using methods described by 
Nordstrom et al. (1977) and Dodd et al. (1982), 
respectively. The Lowry method (Lowry et al., 1951) as 
modified by Peterson (1977) was used to determine the 
protein content in the microsomes. The activity of HMGR was 
expressed as nmoles of mevalonate formed in 30 min per mg 
protein, per whole liver, and per 50 g body weight, while 
that of COH was expressed as percentage conversion of 
cholesterol into 7a-hydroxycholesterol in 40 min per 0.7 mg 
protein. 
Liver microsomal lipid was extracted with 
chloroform/methanol (2:1, v/v) and washed with 0.05 M NaCl 
and 0.36 M CaCl2/methanol (1:1, v/v). The enzymatic method 
(Allain et al., 1974) as modified by Carlson and Goldfarb 
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(1977) was used to determine the total and free cholesterol 
in liver microsomes. 
Feces 
Dried feces were ground in a mortar. An aliquot was 
extracted twice with 0.5 N HCl in absolute ethanol by 
incubation at 37°C for 1 hr (Oh and Dupont, 1975). The 
fecal extract was then saponified in 10% KOH in ethanol at 
60°C for 1 hr. Neutral sterols were extracted with 
petroleum ether, silylated with Sil-prep and analyzed by gas 
chromatography (GC). The GC conditions were the same as 
those for analyzing dietary neutral sterols. The alcoholic 
fraction was acidified to pH 0-2 with 6 N HCl, and bile 
acids were extracted with ethyl ether. Free fatty acids 
were removed from bile acids by thin layer chromatography 
(TLC) using toluene/ethanol/methanol/water/ammonium 
hydroxide (50:20:14:3:1, v/v/v/v/v) as the developing 
solvent. The area of total bile acids was scraped off the 
plate, the bile acids were eluted with methanol, and 
quantitated by using a 3a-hydroxysteroid dehydrogenase assay 
(Weber et al., 1972). Data were expressed as ixg neutral 
sterols or bile acids excreted per 50 g body weight per day. 
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Statistical Analyses 
The mean and standard deviation of each parameter 
measured were calculated for each treatment group. The SAS 
(Statistical Analysis System) computer program for analysis 
of variance was used to test the diet effect, the strain 
effect, and the diet by strain interaction. Comparisons 
between groups were done using student t-test. Pearson 
correlation coefficients between parameters were calculated. 
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RESULTS 
The.results of diet analyses are shown in Tables 8 and 
9. There were some discrepancies between the calculated and 
the analyzed fatty acid compositions. The US74 diet had a 
saturated; monounsaturated: polyunsaturated fatty acid ratio 
of 1.0:0.55:0.24 as opposed to the calculated 1.0:0.90:0.31, 
and the modified fat diet had a ratio of 1.0:0.87:0.91 as 
opposed to 1.0:1.05:1.0. The discrepancies were due to the 
slightly different fatty acid compositions of corn oil and 
beef tallow we used compared with the values in USDA 
Handbook No. 8-4 (Consumer and Food Economics Institute, 
1979). Another reason was that diet ingredients other than 
corn oil and beef tallow might contain a little fat which 
was not counted by calculation. The analyzed cholesterol 
values, however, were the same as the calculated values. 
The US74 diet had 347 mg cholesterol per 1000 Kcal, while 
the modified fat diet had 46 mg cholesterol per 1000 Kcal. 
Corn oil, although containing a negligible amount of 
cholesterol, if any, was high in the phytosterols, 
ergosterol and ^-sitosterol. This was reflected in the 
higher phytosterol content in the modified diet than the 
US74 diet. 
The body and liver weights and food intakes of CBA/J 
and C57BR/cdJ mice are summarized in Table 10. CBA/J mice 
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TABLE 8. Fatty acid compositions of diets and fat sources 
as determined by gas-liquid chromatography 
fatty acid diet fat source 
US74 modified corn oil beef tallow 
weight percent of total fatty acids 
14:0® 2.7 1.6 0.1 3.3 
15:0 0.7 0.4 trace 0.8 
16:0 23.5 18.7 11.0 29.8 
18:0 28.9 15.3 1.2 12.7 
18:1 30.6 31.4 26.9 52.8 
18:2 13.0 31.9 58.9 0.2 
18:3 0.6 0.7 1.9 0.4 
^Number of carbons ; number of double bonds. 
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were heavier, had bigger livers, and ate more than did 
C57BR/cdJ mice. The body weight differences were 
proportional to differences in food intake. The liver 
weights, however, were not directly proportional to body 
weight or food intake. Even as a ratio to body weight, 
CBA/J mice had bigger livers than did C57BR/cdJ mice. The 
liver weight was influenced by the diet. Mice fed modified 
diet had smaller livers than did those fed US74 diet. The 
effect on CBA/J mice was especially obvious. 
Contrary to previous reports, C57BR/cdJ mice had less 
serum total cholesterol than did CBA/J mice (Table 11). 
C57BR/cdJ mice also had less serum high density lipoprotein 
(HDL) cholesterol and esterified cholesterol (EC) than did 
CBA/J mice. The diets used in this experiment did not 
induce hypercholesterolemia as did those used by Roberts and 
Thompson (1975 and 1977). Mice fed the modified diet had a 
lower serum total to HDL-cholesterol ratio than those fed 
US74 diet. 
The activities of HMGR (Table 12) and COH (Table 13) 
were determined in liver microsomes. C57BR/cdJ mice had 
higher cholesterol degradative but lower cholesterol 
synthesis activities than CBA/J mice, as reflected by the 
greater COH activity and lesser HMGR activity. The diet 
effect on these two enzymes was also obvious, especially 
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TABLE 9, Neutral sterol compositions of diets and fat 
sources as determined by gas-liquid chromatography 
neutral sterol diet fat source 
US74 modified corn oil beef tallow 
cholesterol+ 1600 
dihydrocholesterol 
ergosterol 52 
^-sitosterol 270 
Mg/g 
200 27 736 
123 1970 
480 5550 155 
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TABLE 10. Body and liver weights, and food intakes of 2 
strains of mice fed diets with different fat 
compositions (n=8 per group) 
body^'^ liver^ food^ 
strain diet weight weight intake 
g g g/day 
CBA US74 45. 8±2. 2® 2 .72±0 .53® 3.50+0.34® 
CBA modified 43. 8±3. 2® 1 .86±0 .31% 3.3210.06® 
C57BR US74 39. 1±4. 2% 1 .62±0 .24% 2.69±0.14% 
C57BR modified 37. 6±3. 00
 cr
 
1 .35±0 .I7C 2.43±0.19% 
^Values are meansiSD. Values within a column not 
sharing a common superscript are different (P<0.05). 
^Significant strain effect (P<0.01). 
^Significant strain effect (P<0.01), diet effect 
(P<0.01), and strain x diet interaction (P<0.05). 
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HMGR. US74 diet suppressed HMGR activity but increased COH 
activity as an adaptation to the cholesterol content of the 
diet. CBA/J mice showed a greater response to diet than did 
C57BR/cdJ mice in terms of HMGR activity. US74 diet 
suppressed HMGR activity by 80% in CBA/J mice but only 40% 
in C57BR/cdJ mice. 
The total and free cholesterol concentrations in liver 
microsomes were affected by diet, as shown in Table 13. 
US74 diet induced an accumulation of total and free 
cholesterol in liver microsomes. Correlation analysis using 
pooled data showed a negative correlation between HMGR 
activity and total cholesterol in liver microsomes (r=-0.63, 
P<0.01), but, when data within a treatment were used, no 
significant correlations were found. No significant 
correlations between COH activity and cholesterol 
concentration in liver microsomes or serum were found. 
There were significant strain effect, diet effect, and 
strain x diet interaction in fecal excretion of cholesterol 
(Table 14). The US74 diet caused higher fecal cholesterol 
excretion than did the modified fat diet. C57BR/cdJ mice 
showed an especially great response. Those fed US74 diet 
excreted almost five times as much cholesterol as those fed 
the modified diet. The diet effect was also significant in 
fecal excretion of ergosterol, ^-sitosterol and bile acids. 
TABLE 11. Serum cholesterol of 2 strains of mice fed diets with different 
fat compositions (n=8 per group) 
strain diet serum cholesterol ratio 
totall'2 free HDL^ 
EcZ 
/free 
total^ 
/HDL 
mg/dl 
CBA US74 1571173 26.3+7.73 132+103'b 5.210.93 1.20+0. 143 
CBA modified 152+133 25.1+3.23 143+153 5.1+0.73 1.07+0. 06% 
C57BR US74 140±193'b 28.6±5.O3 llB+l&b'C 4.110.7% 1.19+0. 063 
C57BR modified 135+14% 27.0±4.O3 117+lOC 4.210.4b 1.1510. 053 
^Values are means+SD. Values within a column not sharing a common 
superscript are different {P<0.05). 
^Significant strain effect (P<0.01). 
^Significant diet effect {P<0.05). 
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TABLE 12. Liver microsomal hydroxymethylglutaryl CoA 
reductase activity in 2 strains of mice fed diets 
with different fat compositions 
strain diet 
per 
protein 
HMGR^' 
per 
liver 
per 
50g BW 
nmoles mevalonate formed/30 min 
CBA US74 0.3810.08® 12.0+ 2.7® 13.1± 2. 7® 
CBA modified 3.24+1.04b 57.7±23.3^ 65.6±24. 0^ 
C57BR US74 0.19±0.03^ 3.2± O.5C 4.1± 0. 7^= 
C57BR modif ied 0.35±0.13® 5.2± 2.1^ 6.9± 2. 6^^ 
^Values are meansiSD. Values within a column not 
sharing a common superscript are different (P<0.01). 
^Significant strain effect (P<0.01), diet effect 
(P<0.01), and strain x diet interaction (P<0.01). 
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TABLE 13. Liver microsomal total and free cholesterol and 
cholesterol 7a-hydroxylase activity (COH) in 2 
strains of mice fed diets with different fat 
compositions 
strain diet total^'^ free^ COH* 
%g/g liver 
0. 
% conversion/ 
7 mg protein/40 min 
CBA US74 303±26® 249±37® 1.55±0.24® 
CBA modified 188±20^ 171+16^ 1.13±0.22^ 
C57BR US74 285±5lB'C 234±50®'^ 1.74±0.36® 
C57BR modified 244±48^ 189±36^'^ 1.50±0.37® 
^Values are meansiSD. Values within a column not 
sharing a common superscript are different (P<0.01). 
^Significant diet effect (P<0.01) and strain x diet 
interaction (P<0.05). 
^Significant diet effect (P<0.01). 
^Significant strain effect (P<0.05) and diet effect 
(P<0.01). 
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Mice fed the modified diet excreted more ergosterol and 
^-sitosterol than those fed the US74 diet. This was due to 
the high phytosterol concentration in the modified fat diet. 
Bile acid excretion, on the other hand, was greater in mice 
fed the US74 diet than in those fed the modified fat diet. 
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TABLE 14. Fecal excretion of neutral sterols and bile acids 
in 2 strains of mice fed diets with different fat 
compositions 
strain diet chol^'^ ergo^ sito^ BA^ 
f xg /SOg body weight/day 
CBA US74 646± 89® 150124® 514+ 57® 54±15® 
CBA modified 536± 76^ 352±52^ 1070+128^ 40±15® 
C57BR US74 2580±631^ 140131® 543+ 82® 92±36^ 
C57BR modified 519+ 93b 409143^ 1080±127^ 26± 6^ 
^Values are means±SD. Values within a column not 
sharing a common superscript are different (P<0.05). 
^Cholesterol. Significant strain effect (P<0.01), diet 
effect (P<0.01), and strain x diet interaction (P<0.01). 
^Ergosterol. Significant diet effect (P<0.01) and 
strain x diet interaction (P<0.01). 
^/3-sitosterol. Significant diet effect (P<0.01). 
^Bile acids. The values were calculated by using the 
molecular weight of cholic acid. Significant diet effect 
(P<0.05). 
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DISCUSSION 
Diets of different fat contents can be made isocaloric 
by modifying the content of fiber. It is known that fiber 
can affect cholesterol metabolism (Anderson, 1985; Salvioli 
et al., 1985; Mueller et al., 1983). Adolf (1947) reported 
that rats fed a diet diluted with cellulose or kaolin 
consumed enough food to maintain energy intake. Dupont 
(1965) demonstrated that rats were able to adjust their 
energy intake when fat supplied 0 to 40% of the total 
calories. The experimental diets used in this study were 
made isonutrient rather than isocaloric to eliminate the 
effect of fiber. 
Roberts and Thompson (1975 and 1977) reported that the 
C57BR/cdJ mouse was susceptible to and the CBA/J mouse was 
resistant to an atherogenic diet (30 wt% cocoa butter, 5 wt% 
cholesterol, and 30 wt% protein in the form of casein) 
-induced hypercholesterolemia and atheromatous lesions. 
Morrisett et al. (1982) reported similar results. In 
contrast to the extremely high fat,' high saturated fat and 
high cholesterol diet used in those two studies, the present 
study used moderate fat diets similar to a human diet. We 
found that the C57BR/cdJ mouse had lower serum cholesterol 
than the CBA/J mouse when they were fed either a US74 diet 
or a modified fat diet, and there was no significant diet 
effect on serum cholesterol. So, mice hyperresponsive to an 
extremely high fat diet may not be hyperresponsive to a 
moderate fat diet in terms of serum cholesterol level. 
Furthermore, cocoa butter is not present in the American 
diet in large quantities and is very different from beef 
tallow and corn oil in fatty acid compositions. It is 
likely that cocoa butter exerts a different effect from beef 
tallow and corn oil. The reported diet also is deficient in 
essential fatty acids. 
However, Walker (1984) demonstrated that the C57BR/cdJ 
mouse was more responsive to a moderate-fat diet (10% fat as 
lard, olive-sunflower oil, or hydrogenated soy bean-
sunflower oil)-induced elevation of plasma cholesterol than 
was the CBA/J mouse. The different results obtained by 
Walker and in our study may be due to differences in mouse 
age and treatment period. In the present study 6-wk-old 
mice were used compared with 16- to 18-wk-old mice in 
Walker's study, and the treatment period lasted for 8 wk 
instead of 11 wk. Studies with rats hyper- and 
hyporesponsive to diet-induced hypercholesterolemia 
(Takeuchi et al., 1976) showed that the genetic defects in 
hyperresponders were masked when they were young but were 
revealed in the aging process. The combined results of 
Walker and this study may indicate that the aging process 
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aggravates the expression of genetic defects in cholesterol 
metabolism of C57BR/cdJ mice. 
Consistent with the report of Breckenridge et al. 
(1985), most of the plasma total cholesterol in both strains 
of mice used in this study was in the HDL fraction. The 
modified fat diet caused a significantly lower total to HDL 
cholesterol ratio than did the US74 diet. This result is 
consistent with Mulvihill and Walker's finding (1984) that 
the ratio of serum total to HDL cholesterol decreased with 
increasing P/S ratio in the diet. Significant strain 
effects in the distribution of serum cholesterol between 
free and ester ified cholesterol were found. CBA/J mice had 
more cholesterol in the esterified form than C57BR/cdJ mice, 
resulting in a higher serum esterified to free cholesterol 
ratio. 
In this experiment, C57BR/cdJ mice responded to dietary 
cholesterol and fat effects on serum cholesterol equally as 
well as CBA/J mice did although the mechanisms were 
different. CBA/J mice responded to US74 diet by decreasing 
hepatic cholesterol synthesis as a result of suppresssion of 
HMGR activity. C57BR/cdJ mice, on the other hand, responded 
to US74 diet by increasing fecal cholesterol excretion. 
Because both strains had efficient mechanisms to respond to 
the experimental diets used, hypercholesterolemia was not 
seen in either strain of mouse. 
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However, under all conditions, C57BR/cdJ mice had a 
lesser hepatic HMGR activity than did the CBA/J mice. 
Dietschy (1984) compared hepatic cholesterol synthesis in 
several species and concluded that species with high rates 
of hepatic cholesterol synthesis, e.g., the rat, can more 
readily adapt to large changes in the flux of cholesterol 
into and out of the body than can species with much lower 
rates of hepatic cholesterol synthesis, e.g., the hamster 
and man. Moreover, Nestel and Poyser (1976) reported two 
groups of human subjects differing in metabolic responses to 
increased dietary cholesterol intake. Increased fecal 
excretion of cholesterol was the predominant change in one 
group while reduction in cholesterol synthesis was the 
predominant change in the other group. However, a rise in 
the plasma cholesterol level was prevented only when 
cholesterol synthesis was suppressed. The metabolic 
differences between CBA/J and C57BR/cdJ mice were consistent 
with the characteristics of the hyper and hyporesponders in 
humans and other species. 
The US74 diet caused an accumulation of both free and 
total cholesterol in liver microsomes compared to the 
modified fat diet. It also decreased the activity of HMGR 
and increased the activity of COH in the liver microsomes. 
Since both HMGR and COH are membrane-bound enzymes, it is 
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possible that their activities are modulated by the 
cholesterol present in the microsomal membranes either 
through end product inhibition or precursor activation, 
respectively. Correlation analysis using pooled data showed 
a negative correlation between HMGR activity and cholesterol 
concentration in the liver microsomes, but, when data within 
a treatment were used, no correlation was found. This 
suggests that cholesterol concentration may be one factor in 
the gross control of HMGR activity, but fine tuning of the 
enzyme activity is effected by other factors. No 
correlation was found between COH activity and liver 
microsomal cholesterol concentration. Balasubramaniam et 
al. (1973) demonstrated that there were compartments of 
cholesterol in the rat liver microsomes accessible to COH. 
It is likely that compartmentalization for metabolic 
channeling obscured a possible correlation between COH 
activity and COH-accessible cholesterol concentration in the 
liver microsomes. 
In summary, this study has demonstrated marked 
differences in the metabolic response to small changes in 
dietary cholesterol and fat in CBA/J and C57BR/cdJ mice, and 
the genetic defects in cholesterol metabolism of C57BR/cdJ 
mice are not expressed when they are young. This phenomenon 
is very similar to what occurs in humans. CBA/J and 
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C57BR/cdJ mice may serve as good animal models to study the 
genetic predisposition to diet-induced hypercholesterolemia. 
Future research shall investigate the changes in cholesterol 
metabolism during the aging process. 
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ABSTRACT 
Effects of dietary fats on whole body cholesterol 
kinetics were studied in CBA/J (hyporesponders to diet-
induced hypercholesterolemia) and C57BR/cdJ mice 
(hyperresponders). Six-wk-old male mice were fed either a 
US74 diet (40 en% fat, 347 mg cholesterol / 1000 Kcal, 
P/S=0.24) or a modified fat diet (30 en% fat, 46 mg 
cholesterol / 1000 Kcal, P/S=0.91). After 8 wk of feeding, 
0.5 l iCi of ^^C-cholesterol was injected intraperitoneally 
into each mouse and mice were killed at intervals over 34 
days. The mass and radioactivity of cholesterol in serum, 
heart, liver and carcass were determined. 
Mice fed the US74 diet had more cholesterol in the 
liver than did those fed the modified fat diet, and the 
C57BR/cdJ strain had less cholesterol in serum, liver and 
carcass but more in heart compared to the CBA/J strain. The 
kinetic data were consistent with the cholesterol mass data 
as mice fed the US74 diet had lower initial specific 
radioactivity than those fed the modified fat diet, and 
CBA/J mice had lower initial specific activity than did 
C57BR/cdJ mice, reflecting a greater dilution of the 
radioactive cholesterol by unlabeled cholesterol in the 
liver. 
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Computer analysis using a three-compartment model 
(serum, heart and liver) showed that liver and serum 
compartments were in rapid balance in mice fed the modified 
fat diet and in C57BR/cdJ mice fed the US74 diet. The CBA/J 
mice fed the US74 diet, however, had a delay in the balance 
between liver and serum compartments. The heart showed an 
initial buildup of radioactivity, and the radioactivity 
started to die away after 4 days. The higher cholesterol 
specific activity in heart than in liver or serum of the 
C57BR/cdJ strain fed the modified fat diet and the lower 
cholesterol specific activity in the carcass than in other 
tissues of both strains fed either diet probably reflected 
two or more sub-compartments in heart and carcass which were 
not in rapid balance. Further analysis is in progress to 
incorporate carcass into the model and to improve the level 
of confidence in the calculated transfer rates. 
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INTRODUCTION 
Whole body cholesterol metabolism has been customarily 
studied by following the decline of plasma cholesterol 
specific activity over time after a single injection of 
tracer. Each change of slope of the curve is usually 
interpreted as indicating a different kinetic pool of 
cholesterol. By the curve peeling technique, Goodman and 
Noble (1968) described two kinetically distinct pools of 
cholesterol in normal persons, untreated hyperlipidemic 
patients and hyperlipidemic patients treated with 
cholestyramine. Similar to the human, miniature swine 
(Dupont et al., 1974) also showed a two component 
disappearance curve in serum. Later, a three component 
disappearance curve was reported by Goodman et al. in 1973 
based on an experiment done on humans over longer periods of 
time. The pools were postulated to represent tissues having 
different rates of equilibrium of cholesterol with serum 
cholesterol. The three major body cholesterol compartments 
were thought to be: a rapidly miscible pool, a slowly 
miscible pool, and a very slowly miscible pool. These 
pools, however, only represented mathematical constructs and 
did not have precise physical meaning. The curves did not 
define the characteristics of cholesterol within pools nor 
the location of the compartments. Studies of tissue 
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cholesterol metabolism suggested that the rapidly miscible 
pool contained cholesterol in the liver, plasma, red blood 
cells and intestine; the slowly miscible pool contained 
muscle and adipose cholesterol; and the very slowly miscible 
pool contained cholesterol of brain and nervous tissue 
(Dupont, 1982). 
The three-pool model does not account for what is known 
about cholesterol metabolism. Mitropoulos et al. (1974) 
found that the rat liver contained one compartment of 
cholesterol accessible to cholesterol 7a-hydroxylase (COH) 
and a separate compartment available for lipoprotein 
synthesis. Balasubramaniam et al. (1973) reported that the 
COH-accessible pool consisted of de novo synthesized 
cholesterol while the other pool represented turnover of 
serum cholesterol. In other words, in vivo turnover of 
cholesterol actually involves a large number of 
metabolically heterogeneous pools of cholesterol in 
different tissues and within given tissues. Schwartz et al. 
(1978) used a simulation analysis and modeling (SAAM) 
process to characterize the hepatic bile acid and biliary 
cholesterol precursor sites in patients with total bile 
fistula. A model was designed using current knowledge of 
cholesterol metabolism and was then tested by a computer 
simulation program to determine whether the data fit. With 
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this approach, Schwartz et al. (1978) concluded that 31% and 
20%, respectively, of the cholesterol input into the bile 
acid and biliary cholesterol precursor sites were derived 
from newly synthesized hepatic cholesterol, 10% of bile acid 
from plasma esterified cholesterol, and the remainder 
predominantly from lipoprotein-free cholesterol. 
In human studies, blood is almost the only available 
tissue for analysis except, in a few cases, bile is also 
available. Animal studies, however, can provide more 
information as each tissue can be analyzed. A previous 
study (Kuan and Dupont, 1987) showed that dietary fat 
composition affected cholesterol metabolism in mice and 
different strains of mice responded to diet differently. 
When fed a diet with 40 en% fat (P/S=0.24) and 346 mg 
cholesterol / 1000 Kcal compared to a diet with 30 en% fat 
(P/S=0.91) and 46 mg cholesterol / lOOO Kcal, CBA/J mice 
maintained cholesterol homeostasis by suppressing hepatic 
cholesterol synthesis while C57BR/cdJ mice increased fecal 
excretion of cholesterol. The CBA/J strain was described as 
resistant to and the C57BR/cdJ strain as susceptible to 
diet-induced hypercholesterolemia and atherosclerosis 
(Roberts and Thompson, 1975 and 1977). 
In the study reported herein a mathematical modeling 
approach based on a phenomenological model was used to 
102 
investigate how diets and genetics affected whole body 
cholesterol kinetics in mice. 
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METHODS 
Experimental Design 
C57BR/cdJ (susceptible to diet-induced atherosclerosis) 
and CBA/J (resistant) mice were purchased from the Jackson 
Laboratory (Maine) and bred in the Animal Care Facility of 
the Food and Nutrition Department, Iowa State University. 
The diet used in the breeding colony was Purina Breeder 
Chow. At 6 wk of age, male mice were caged singly in a room 
with a reversed light cycle (light: 1700-0500 h; dark; 
0500-1700 h) and fed either a US74 or a modified fat diet 
(Kuan and Dupont, 1987). The two experimental diets were 
isonutrient and were based upon that devised by Fanelli and 
Kaplan (1978) with variation in fat composition. The US74 
diet had a fat content similar to that of the average 
American diet in 1974 in accord with the HANES I survey 
(Abraham and Carroll, 1979) (40% of energy from fat, 600 mg 
cholesterol / 2000 Kcal, and a P/S ratio of 0.3), while the 
modified fat diet was designed to meet the Dietary Goals for 
the United States (1977) (30% of energy from fat, less than 
300 mg cholesterol / 2000 Kcal, and a P/S ratio of 1.0). 
After 8 wk of feeding, 0.5 AtCi of [4]^^C-cholesterol was 
injected intraperitoneally to each mouse. Mice were killed 
at intervals over 34 days. 
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Tissue Analyses 
Mice were anesthetized with ether and blood was 
obtained after decapitation. Serum was prepared by allowing 
blood to clot at room temperature and then centrifuging at 
2,000 X g for 10 min. Liver and heart were excised. Serum, 
liver, heart and the eviscerated carcass were stored at 
-80°C until analysis. 
Liver, heart and serum were saponified in 10% ethanolic 
KOH at 60°C for 1 h (Dupont et al., 1982). The 
nonsaponifiable fraction was extracted twice with petroleum 
ether. An aliquot of the extract was taken for cholesterol 
mass determination (Carlson and Goldfarb, 1977). The 
remaining extract was transferred to a scintillation vial, 
dried and counted for radioactivity in a Packard TRI-CARB 
liquid scintillation spectrometer using ScintiLene (Fisher 
Scientific Co.) as the scintillation fluid. This gave an 
estimate of radioactive cholesterol present. The carcass 
was hydrolyzed in 10% KOH in 50% aqueous ethanol at 80°C for 
4 h (Dupont et al., 1980). The nonsaponifiable fraction was 
extracted and analyzed in the same way as the other organs. 
105 
Data Analyses 
In this experiment, it was assumed that mice were in a 
steady state of cholesterol metabolism. In other words, the 
cholesterol masses in different organs and carcass were 
constant among mice of the same treatment and there should 
be no time effect on the distribution of cholesterol mass. 
Any data point having cholesterol mass outside the mean±2SD 
was omitted from the analysis. Then, an analysis of 
variance using the SAS (Statistical Analysis System) 
computer program was carried out to test whether there was a 
time effect. When there was, outlying points were dropped. 
The data were then subjected to the analysis of variance to 
test the diet effect, the strain effect, and the diet by 
strain interaction. 
Specific radioactivity (dpm/mg) was determined as a 
function of time for cholesterol in each organ and the 
eviscerated carcass minus the head. Adjustment was made to 
14 
correct for differences in body weight and radioactive C-
cholesterol dose. A mathematical model (Figure 1) was 
constructed based on the exchange of tracers between 
compartments, and a computer program was written. The 
differential equations that describe the variation of the 
specific activity of cholesterol in each compartment with 
time were then written as follows. 
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Serum compartment 
Mg (dYg/dt ) =Rhs%'*'^ LS L^'*'^ TS^T~ (RST+RSH+^SL) 
+(Ecf/(l-f))YL 
Liver compartment 
ML(dYL/dt)=RsLYs-((Ec/(l-f))+Rls+Tl)Yl 
Heart compartment 
%(dt)=RSHYS"(RHS+TyiYH 
Tissue compartment 
Miji ( dYiji/dt ) "RgT^S" ( ^^S^^T ^ Yip 
where the symbols are defined as follows; 
Mi=mass of cholesterol in compartment i 
Rij=transfer rate of cholesterol from compartment i to j 
Ti=rate at which cholesterol is converted 
Bc=excretion rate 
Yi=labeled cholesterol/total cholesterol in compartment i 
The assumptions underlying this model are as follows. 
1) Total cholesterol is at a steady-state 
2) Each compartment is well-mixed 
Under these conditions, the only variables in these 
equations are the Y's. The data from the experiments were 
then fit with a 3rd-order spline fit, and the equations were 
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solved by using a numerical integration scheme on a digital 
computer. A regression routine was used to adjust the 
values of the constants representing the transfer rates 
until a satisfactory fit between the data and the numerical 
solutions was obtained. This technique has the advantage of 
producing the flow rates directly, in contrast to curve-
peeling techniques. It also allows testing of alternate 
hypotheses regarding the movement of cholesterol. 
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tissue 
SH "HS 
heart serum 
TH 
IÊ i-f 
Ec 
FIGURE 1. Four-compartment model of cholesterol flow in the 
body (R»rate of cholesterol flow; S=cholesterol 
synthesis; T=conversion of cholesterol; 
f=fraction of cholesterol recycled; 
Ec=cholesterol excretion) 
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RESULTS 
The cholesterol masses in serum, heart, liver and 
carcass are shown in Table 15. Strain effect was 
significant in all these organs. C57BR/cdJ mice had less 
cholesterol in serum, liver and carcass, but more in heart 
compared with CBA/J mice. The diet effect was significant 
in liver and carcass only. Mice fed the US74 diet had 
higher accumulations of cholesterol in liver and carcass 
than those fed the modified fat diet. 
The computer model described earlier was employed to 
analyze the kinetic data. It was found that transformation 
of labeled cholesterol (the T^'s) was negligible, and that a 
satisfactory fit was best obtained using a three-compartment 
model (serum, heart and liver), and ignoring the tissue 
(carcass) compartment. The raw data of carcass are shown in 
Table^ 16. Figures 2, 3, and 4 showed the specific activity 
time course of experimental data and computer-generated 
curves in serum, heart and liver, respectively, using CBA/J 
mice fed a US74 diet as an example. The computer-generated 
specific activity time course curves to fit the serum, heart 
and liver data of CBA/J and C57BR/cdJ mice fed diets with 
different fat compositions are shown in Figures 5, 6 and 7, 
respectively. Figures 8, 9, 10 and 11 are overlay of 
computer-generated serum, heart and liver curves for 
TABLE 15. Cholesterol masses in seriom, heart, liver and carcass of 2 strains 
of mice fed diets with different fat compositions {n=30-36 per 
group) 
strain diet 1 2 serum-^ ' ^ heart^ •1 • 4 liver 5 carcass^ 
mg/dl mg/50g body weight 
CBA US74 161±16® 0 .298+0.0283 35.5+9.63 67.4111.93 
CBA modified 158±22^ 0 .29510.028^ 7.8±2.G^ 66.0± 9.43 
C57BR US74 156125®'^ 0 .323+0.038% 2O.3+3.9C 57.0+ 6.2b 
C57BR modified 144±2lC 0 .32010.057^ 7.4±1.0b 50.8+ 5.6C 
^Values are meanstSD. Values within a column not sharing a common 
superscript are different (P<0.05). 
^Significant strain effect (P<0.05). 
^Significant strain effect {P<0.01). 
^Significant strain effect (P<0.01), diet effect (P<0.01) and strain x 
diet interaction (P<0.01). 
^Significant strain effect (P<0.01) and diet effect (P<0.01). 
Ill 
different groups of mice. Table 17 gives the calculated 
exchange flows which are consistent with the figures. 
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TABLE 16. Specific activity time course in carcass of 2 
strains of mice fed diets with different fat 
compositions after an injection of radioactive 
cholesterol (n=2-4 per time point) 
strain CBA C57BR 
diet US74 modified US74 modified 
day lO^dpm/mg 
1 21.4 24.7 27.3 50.9 
2 22.3 24.0 18.7 48.2 
4 31.2 45.7 29.8 41.7 
6 11.6 23.0 17.7 23.8 
10 12.0 11.9 14.8 19.3 
13 12.4 22.7 12.2 24.0 
16 11.0 15.4 14.4 37.3 
20 7.4 12.3 7.4 24.3 
23 8.4 13.6 10.7 18.5 
26 6.2 9.3 8.2 11.9 
30 5.5 15.1 10.4 25.4 
34 4.4 7.9 7.2 17.8 
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Specific activity time course in heart of CBA/J mice fed a US74 
diet after an injection of radioactive cholesterol {stars=actual 
values, line=computer-generated curve) 
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FIGURE 5. Computer-generated specific activity time course curves fitting 
the serum data of 2 strains of mice fed diets with different fat 
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FIGURE 6. Computer-generated specific activity time course curves fitting 
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compositions 
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FIGURE 7. Computer-generated specific activity time course curves fitting 
the liver data of 2 strains of mice fed diets with different fat 
compositions 
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FIGURE 8. Overlay of the computer-generated specific activity time course 
curves of servim, heart, and liver in CBA/J mice fed a US74 diet 
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FIGURE 9. Overlay of the computer-generated specific activity time course 
curves of serum, heart, and liver in CBA/J mice fed a modified fat 
diet 
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FIGURE 10. Overlay of the computer-generated specific activity time course 
curves of serum, heart, and liver in C57BR/cdJ mice fed a US74 
diet 
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TABLE 17. Calculated exchange flows of cholesterol between 
compartments based on a three-compartment model 
(serum, heart, and liver) 
strain diet f® 
CBA US74 
CBA modified 
C57BR US74 
C57BR modified 
0.0069 0.011 
0.0139 0.328 
0.0077 0.072 
0.0015 0.017 
fraction 
0.059 0.096 
0.166 0.022 0.899 
0.037 0.050 0.443 
0.007 0.026 0.084 
^Transfer rate of cholesterol between heart and serum. 
^Transfer rate of cholesterol from serum to liver. 
^Transfer rate of cholesterol from liver to serum. 
^Excretion rate of cholesterol. 
^Fraction of cholesterol recycled. 
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DISCUSSION 
The cholesterol mass data showed that CBA/J mice 
accumulated more cholesterol in the liver and carcass 
compared to C57BR/cdJ mice. Results are consistent with our 
previous study (Kuan and Dupont, 1987) showing that CBA/J 
mice had higher hepatic hydroxymethylglutaryl coenzyme A 
reductase activity but lower fecal cholesterol excretion 
than C57BR/cdJ mice. The high capacity of the CBA/J mouse 
to store cholesterol in the liver and carcass compared with 
the C57BR/cdJ mouse may be one factor explaining their 
resistance to diet-induced hypercholesterolemia. On the 
contrary, C57BR/cdJ mice stored more cholesterol in the 
heart compared with CBA/J mice. Since atherosclerosis 
occurs in coronary artery walls, the high accumulation of 
cholesterol in the heart of the C57BR/cdJ mouse may be one 
factor predisposing this strain to diet-induced 
atherosclerosis. 
Mice fed the US74 diet had lower initial specific 
activity than those fed the modified fat diet and CBA/J mice 
had lower initial specific activity than C57BR/cdJ mice, 
reflecting a greater dilution of the radioactive cholesterol 
by unlabeled total cholesterol in the liver. The kinetic 
results are consistent with the cholesterol mass data which 
showed that CBA/J mice had more cholesterol in the liver 
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than C57BR/cdJ mice and mice fed the US74 diet had more 
cholesterol in the liver than those fed the modified fat 
diet. 
The slope of the curve represents the rate of 
cholesterol turnover. The greater change in the slope of 
the serum, liver and heart curves of C57BR/cdJ mice fed the 
modified fat diet compared to other treatment groups 
indicates that this group of mice had a faster fractional 
turnover of cholesterol. 
Liver and serum were in rapid balance except in CBA/J 
mice fed the US74 diet. Study with rats (Oh et al., 1976) 
demonstrated a rapid balance between serum and liver, but 
skeletal muscle and kidney had a slow buildup of 
radioactivity. In this study, mice also showed an initial 
buildup of radioactivity in the heart, and the radioactivity 
started to die away after 4 days. The specific activity 
time course curves of heart in C57BR/cdJ mice fed the US74 
diet and in CBA/J mice fed either diet followed a regular 
precursor-product relationship with serum curves. The 
C57BR/cdJ mice fed the modified fat diet, however, showed a 
different result. The heart had higher cholesterol specific 
activity than did the liver or serum after 4 days, possibly 
reflecting the presence of two or more different sub-
compartments in the heart which were not in rapid balance. 
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The specific activity in carcass (tissue) was lower 
than that of other compartments throughout the time course 
studied. This may suggest that carcass is composed of two 
cholesterol compartments — one is in balance with the serum 
while the other is inaccessible to serum. Further analysis 
is in progress to incorporate carcass data into the model 
and to improve the level of confidence in the calculated 
transfer rates. 
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DISCUSSION 
The activity of cholesterol 7a-hydroxylase (COH) in 
liver microsomes is usually determined by measuring the 
percentage conversion of radioactive cholesterol into 
radioactive 7a-hydroxycholesterol. Since liver microsomes 
contain appreciable amounts of cholesterol, the radioisotope 
method is influenced by the mixing of the exogenous 
radioactive cholesterol and the endogenous cholesterol 
present in the liver microsome. It is known that the added 
radioactive cholesterol mixes with the endogenous 
cholesterol to different extents, depending on the way in 
which it is added (Mitropoulos and Balasubramaniam 1972). 
Furthermore, Balasubramaniam et al. (1973) and Bjorkhem and 
Danielsson (1975) have presented evidence for the 
compartmentation of cholesterol in rat liver microsomes. 
They reported that not more than 70% of the cholesterol in 
rat liver microsomes is immediately accessible to COH. So, 
a better assay for COH would be one using endogenous 
cholesterol as the substrate. Bjorkhem and Danielsson 
(1974) described a combined gas chromatography-mass 
spectrometry (GC-MS) method to measure 7a-hydroxycholesterol 
formed from endogenous cholesterol. Sanghvi et al. (1978) 
simplified the procedure and used it to measure oxygenated 
derivatives of cholesterol. Galli-Kienle et al. (1984) 
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applied the method to assaying the activities of 
hydroxymethylglutaryl coenzyme A reductase and COH. 
In order to avoid the problems related to the 
equilibration between the exogenous and endogenous 
cholesterol, we tried to adopt the GC-MS method to determine 
the activity of COH in our samples. Trials using standards 
indicated that cholesterol and the internal standard 
5a-cholestane gave good results with GC (Bendix 2500 gas 
chromatograph equipped with a flame ionization detector and 
a 6 ft X 3 mm ID, 6 mm OD glass column packed with 4% 
SE30/6% QFl, 100-120 mesh; instrument settings were; column 
temperature 230° and 250°C, and nitrogen flow 80 ml/min). 
MS analysis with solid or desorption probe at 280°C, or GC-
MS (Finigan model 2400 with model 2500 source, and TEK-N-
VENT model 3000 data system) gave nice spectra. However, 
problems arose during the determination of 
7a-hydroxycholesterol concentration. It could be detected 
with GC or MS alone, but not GC-MS. Results are.shown in 
Table 18. A number of manipulations were made, including 
changing the column (3% OVIOI, 1% 0V17, 3% 0V17, and 4% 
SE30/6% QFl) and column temperature (210°, 230°, and 250°C), 
and preparing different derivatives (trimethylsilyl (TMS) 
ether and ethyl diazoethane ether; because the TMS 
derivatives plugged the GC detector after 1-2 samples. 
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partition was performed to get a cleaner sample). 
7a-Hydroxycholesterol still did not show up in GC-MS. We 
found that this compound was degraded in the GC column on 
MS. Another alternative was to use a capillary or Megabore 
column instead of a packed column. Because of the 
anticipated lengthy time involved, we turned to search for a 
simpler method. 
Thin layer chromatography (TLC) for separation, 
densitometer for quantitation and MS for identification 
seemed to be a suitable compromise. 7a-Hydroxycholesterol 
was separated from cholesterol by using TLC plates with a 
fluorescent indicator. When viewing under a UV lamp, one 
could easily tell which sample had COH activity as 
7a-hydroxycholesterol was seen only in samples after 
incubation. However, the amount of 7a-hydroxycholesterol 
formed, thus the fluorescence was too small to be 
quantitated accurately by the densitometry used (Kontes 
Scanner model 800). The Rf values of cholesterol and its 
oxygenated derivatives are shown in Table 19. We also tried 
to determine the intensity of the color formed after 
charring the sulfuric acid sprayed plate of a mouse liver 
microsome extract. The color was barely visible. So, this 
TLC-dens, .ometry method did not seem to be a suitable method 
to detect the small amount of 7a-hydroxycholesterol in the 
samples. 
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TABLE 18. Retention times of 5a-cholestane, cholesterol and 
oxygenated sterols separated by gas 
chromatography (GC) or gas chromatography-mass 
spectrometry (GC-MS) 
GC^ GC-MS^ 
min 
5a-cholestane 12^ 5^ 2.7® 2.8^ 
7a-hydroxy-cholesterol 26 11 no peak no peak 
cholesterol 29 11 8 7.7 
7/3-hydroxy-cholesterol 36 14.6 no data no data 
7-keto-cholesterol no data 27.1 no data no data 
Bendix 2500 gas chromatograph equipped with a flame 
ionization detector; 6 ft x 3 mm ID, 6 mm OD glass column 
packed with 4% SE30/6% QFl, 100-120 mesh; nitrogen flow 80 
ml/min; trimethylsilyl derivatives were used, 
^GC-MS Finigan model 2400 with model 2500 source, and a 
TEK-N-VENT model 3000 data system; column temperature 250"C; 
6 ft X 3 mm ID glass column packed with 4% SE30/6% QFl. 
^Column temperature 230°C. 
^Column temperature 250°C. 
^Trimethylsilyl derivatives after partition with 
methylene chloride. 
^Ethyl diazoethane derivatives. 
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For time's sake, further pursuit on methodology was 
given up and the original radioisotope method was used. 
Balasubramaniam et al. (1973) reported that Tween 80 was 
better than acetone to bring radioactive cholesterol into 
the substrate pool. So, Tween 80 was used to solubilize 
radioactive cholesterol in this experiment to maximize the 
equilibration between exogenous and endogenous cholesterol. 
Future studies on measuring COH activity using 
endogenous cholesterol as the substrate shall focus on the 
GC-MS method. Our trial with a Megabore column (Megabore 
DB-5 from J and W Scientific, 15 m x 0.53 mm ID, column 
temperature 180°C, nitrogen flow 10 ml/min) showed that 
7a-hydroxycholesterol could be detected though the 
sensitivity was low (retention time=3 min, 1% total ion 
current for 0.8 jug). The advantage of using a Megabore 
column is that compounds can be eluted faster than with 
capillary column. Increasing the sensitivity using a 
Megabore column should be suitable for determining COH 
activity from endogenous substrate by analyzing for 
7a-hydroxycholesterol and cholesterol concentrations. 
Levels of plasma cholesterol usually seen in Western 
industrialized countries are inappropriately high. Diet and 
heredity are two major factors. A diet rich in saturated 
fat and cholesterol is known to elevate the plasma 
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TABLE 19. Rf values of cholesterol, oxygenated sterols and 
zearalenone separated by thin layer 
chromatography 
Rf* 
7a-hydroxy-cholesterol 0.19 
7p-hydroxy-cholesterol 0.22 
7-keto-cholesterol 0.28 
cholesterol 0.50 
zearalenone 0.55 
cholesteryl ester 0.76 
Compounds were separated on a silica gel TLC plate 
(Fisher Scientific, 20 cm x 20 cm, 0.25 mm thickness) using 
ethyl acetate ; benzene (3/2, v/v) as the developing solvent 
in a filter-paper lined saturated tank. The TLC plate had 
been activated in a lOCC oven for 1 hr. 
135 
cholesterol level, but the level does not rise equally in 
every person. Brown and Goldstein (1986) developed a model 
to explain the dietary eff^ect on blood cholesterol. In this 
model, the major factor determining the plasma LDL-
cholesterol concentration is the number and saturation of 
hepatic LDL receptors. When a diet rich in saturated fat 
and cholesterol is consumed, excess dietary cholesterol 
accumulates in the liver which results in reduced production 
of LDL receptors and increased production of VLDL and IDL. 
Only a small part of the IDL is removed by LDL receptors 
owing to the decreased number of LDL receptors. The 
remainder is converted to LDL. For the same reason, the 
removal rate of LDL also decreases. As a result of the 
combined effects of increased production and decreased 
removal of LDL, the plasma LDL cholesterol level increases. 
The individual differences in susceptibility to diet-
induced elevation of blood cholesterol suggest that genetics 
plays a role as well. These studies demonstrated the 
metabolic differences between CBA/J and C57BR/cdJ mice in 
the responses to diet. Such differences are consistent with 
results of animal and human studies on cholesterol 
metabolism in hypo and hyperresponders to dietary fat. 
CBA/J mice responded to a high-fat diet by suppressing 
hepatic cholesterol synthesis while C57BR/cdJ mice increased 
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fecal cholesterol excretion. No elevation of serum 
cholesterol was detected in this experiment, not even in the 
purported susceptible strain, C57BR/cdJ, because of the 
efficient compensatory mechanisms. However, Roberts and 
Thompson (1975, 1977) reported a large elevation of blood 
cholesterol in C57BR/cdJ mice and only a slight elevation in 
CBA/J mice when they were fed an extremely high saturated 
fat and cholesterol diet. Walker (1984) found that 
C57BR/cdJ mice were more responsive than CBA/J mice to a 
moderate level of dietary fat after 11 wk of feedings of 16-
to 18-wk-old mice. 
Based on Brown and Goldstein's model, the genetic 
susceptibility to diet-induced elevation of blood 
cholesterol can probably be explained by the number of LDL 
receptors in the liver. In dogs the production of hepatic 
LDL receptors has been shown to decrease with age (Goldstein 
et al., 1983). The different results of this study and 
Walker's study can probably be explained by aging effects on 
LDL receptors. The C57BR/cdJ mouse may have an efficient 
LDL receptor activity when young, thus showing a lower serum 
cholesterol concentration than the CBA/J mouse in the 
present study. However, the LDL receptors in the C57BR/cdJ 
mouse may decrease in number much faster than in the CBA/J 
mouse during the aging process so that the C57BR/cdJ mouse 
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responds to dietary fat less efficiently than the CBA/J 
mouse when older. That may be why the C57BR/cdJ mouse was 
more responsive to the diet than the CBA/J mouse in Walker's 
study. This model can explain very well the diet and age 
effects on blood cholesterol level. However, it cannot 
explain the metabolic differences between these two strains 
of mice. 
Modification of the Brown and Goldstein model is 
proposed to explain such differences. Like the Brown and 
Goldstein model, liver is considered a major organ in the 
control of blood LDL in this model. Its importance is 
reflected by the fact that most LDL is removed from the 
plasma by the liver and more than 90% of this clearance 
process is mediated by LDL receptors (Dietschy, 1984). Two 
types of receptors are present in the liver — remnant 
receptor and LDL receptor. Both receptors recognize 
apoprotein E. The remnant receptor binds only exogenous 
lipoproteins (chylomicron remnant), but the LDL receptor 
binds endogenous lipoproteins (IDL and LDL) as well as 
exogenous lipoproteins (Brown and Goldstein, 1985). This 
model proposes that the C57BR/cdJ mouse differs from the 
CBA/J mouse in the hepatic remnant and LDL receptors — it 
has either defective or less remnant receptors, but more LDL 
receptors. 
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When a low-fat diet is fed to the CBA/J mouse, 
chylomicron remnants generated are removed efficiently by 
remnant receptors and the small amount of IDL and LDL are 
taken up by LDL receptors, leaving a very low level of LDL 
in the blood. At ordinary intakes of dietary fat, the major 
factor that limits the removal of LDL from blood is 
saturation of the LDL receptor. When a high-fat diet is 
fed, more VLDL is formed, resulting in more IDL and LDL. 
LDL receptors become saturated. The cholesterol derived 
from internalized LDL through the LDL receptor has the 
properties of suppressing the HMGR activity, down-regulating 
the LDL receptor and activating the ACAT (Brown and 
Goldstein, 1979). So, the saturation and suppression of 
hepatic LDL receptor contributes to the build-up of LDL in 
plasma. 
When the C57BR/cdJ mouse is fed a low-fat diet, the 
small amount of chylomicron remnants can either be removed 
by the remnant receptor alone or by a combination of remnant 
and LDL receptors. Because the C57BR/cdJ mouse has a lower 
blood LDL level, it must have higher LDL receptor activity 
than the CBA/J mouse. This model also explains the greater 
response of the C57BR/cdJ mouse to a high-fat diet compared 
to the CBA/J mouse. When a high-fat diet is fed, the 
remnant receptors cannot cope with the large amount of 
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chylomicron remnants, and some of the remnants compete with 
IDL and LDL for LDL receptors. Since chylomicron remnants 
have both apo E and apo B-48 while LDL has apo B-lOO only, 
the LDL receptor has higher affinity towards chylomicron 
remnants and the chylomicron remnant is the winner in the 
competition. The high-fat diet also causes increased 
secretion of VLDL thus IDL and LDL to the blood. As a 
result of the saturation and suppression of hepatic LDL 
receptors, increased production of LDL, and the strong 
competition from chylomicron remnants for LDL receptors, LDL 
accumulates to a very high level. 
This model predicts that the diet-induced elevation of 
blood cholesterol is in the LDL fraction. Unlike humans, 
the major lipoprotein in mice is HDL. Breckenridge et al. 
(1985) reported that for both CBA/J and C57BR/cdJ mice fed a 
commercial laboratory diet, over 90% of the plasma total 
cholesterol was in the HDL fraction, with extremely low 
values in the VLDL and LDL fractions. The present results 
confirm their findings. Despite this fact, the model is 
applicable to the CBA/J and C57BR/cdJ mice since for both 
strains, the atherogenic diet-induced increase in plasma 
cholesterol is in the VLDL, IDL and LDL fractions 
(Breckenridge et al., 1985; Morrisett et al., 1982). 
140 
This model can also explain the different cholesterol 
synthesis and excretion rates and cholesterol accumulation 
in the liver between the two strains of mice. Suppose that 
the HMGR activity and cholesterol excretion are controlled 
by the cholesterol internalized through the LDL receptors 
and the cholesterol accumulation is more affected by the 
remnant receptors. When a moderate-fat diet is fed, both 
strains store little cholesterol in the liver. Because only 
a very small amount of cholesterol enters the liver through 
LDL receptors in the CBA/J mouse, the CBA/J mouse has high 
hepatic HMGR activity and low excretion of cholesterol in 
the feces. The C57BR/cdJ mouse, however, has more 
cholesterol entering through LDL receptors because of more 
LDL receptors and the processing of chylomicron remnants in 
addition to LDL. Consequently, the C57BR/cdJ mouse has 
suppressed hepatic HMGR activity. When a high-fat diet is 
fed, the CBA/J mouse accumulates a large amount of 
cholesterol in the liver due to the efficient remnant 
receptor system and its nondown-regulation property. An 
appreciable amount of cholesterol also enters the liver 
through the LDL receptor, leading to the suppression of HMGR 
activity and increased cholesterol excretion. The C57BR/cdJ 
mouse also accumulates an increased amount of cholesterol in 
the liver compared to when a moderate-fat diet is fed, but 
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the level is much less than the CBA/J mouse because of the 
defective or inefficient remnant receptor system and the 
down-regulation of the LDL receptor. Again, the high level 
of cholesterol which enters the liver through the LDL 
receptor further suppresses the HMGR activity and increases 
the cholesterol excretion. The aging effect on cholesterol 
metabolism is interpreted as a decreased number of LDL 
receptors. 
With present knowledge one cannot judge which model is 
correct or if both are wrong. The confirmation or 
modification of the proposed models or the establishment of 
a new model shall await future research. It is also 
uncertain whether this model is applicable to humans and 
whether the mouse which differs so much in its lipoprotein 
profile from the human is the best animal model to study 
cholesterol metabolism in comparison to the human. However, 
judging from present knowledge, it seems that the responses 
to diet in mice are similar to those of humans and that the 
CBA/J and C57BR/cdJ mice are good models to study 
cholesterol metabolism in hypo- and hyperresponders. All 
patients of familial hypercholesterolemia show evidence of 
defects in the LDL receptors, but not all defects are the 
same (Brown and Goldstein, 1986). It is likely that the 
causes of diet-induced hypercholesterolemia are also 
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multiple and the proposed defect in this report is just one 
of them. 
Evidence has shown that there are indiviual variations 
in susceptibility to diet-induced hypercholesterolemia. The 
question arises whether dietary recommendations to 
hyperresponders should be different from those to 
hyporesponders. A Consensus Conference (1985) on "Lowering 
blood cholesterol to prevent heart disease" sponsored by the 
National Institutes of Health recommended that all Americans 
above 2 years old should reduce dietary fat to less than 30% 
of total calories, increase polyunsaturated fat to 10% of 
calories, and reduce dietary cholesterol to 250-300 mg or 
less per day. Alfin-Slater (1987) commented that these 
recommendations could translate into a diet very limited in 
animal protein and other associated nutrients, and an 
increase in cereal grains at the expense of animal products 
might result in a decrease of some protective micronutrients 
such as vitamins and minerals and thereby pose health risks 
to children. Furthermore, a low-fat, high-carbohydrate diet 
may be harmful to some old or carbohydrate intolerant people 
(Reaven, 1986). Nevertheless, the recommendations for 
change are quite moderate and unlikely to result in such 
large effects unless individuals over-respond to the diet. 
When these possible harmful effects are taken into 
143 
consideration, should all Americans follow the 
recommendations? Should the recommendations be given to 
hyperresponders only? Can the hyporesponders be free from 
such dietary modifications? These questions still remain 
unanswered. Judging from the serum cholesterol level only, 
it seems that a prudent diet is neither necessary nor 
beneficial for the hyporesponders. However, this study 
shows that hyporesponding mice fed a high-fat diet store 
much cholesterol in the liver. Will it cause damage to the 
liver? One difficulty in dietary recommendations is that we 
have to consider the general health of a person. A diet 
good for a certain organ, however, may not be good for other 
organs. Recommendations on severe dietary changes to all 
Americans seem premature at this time. Until more research 
has been done, the best advice is moderate consumption of 
dietary fat and choices from a variety of foods. The 
present study demonstrates that there exist metabolic 
differences between the CBA/J and C57BR/cdJ mice in the 
response to diet, and such differences are consistent with 
the human data (Nestel and Poyser, 1976). This suggests 
that the CBA/J and C57BR/cdJ mice provide a good animal 
model for future investigations of dietary effects and may 
lead to answers to the above questions. 
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APPENDIX Aî PREPARATION OP LIVER MICROSOMES 
Materials 
Homogenizing buffer; 0.1 M potassium phosphate buffer (KPi) 
(pH 7.4) containing 0.25 M sucrose, 0.03 M nicotinamide, 
0.001 M dithiothreitol and 0.001 M disodium EDTA 
Procedure 
The liver sample was held on ice throughout the whole 
procedure. The liver was minced, homogenized in a Potter-
Elvehjem tissue grinder with 4 volumes of homogenizing 
buffer, and centrifuged at 20,000 x g in a J2-21 Beckman 
high speed refrigerated centrifuge for 30 min. The 
supernatant was transferred to an ultracentrifuge tube for 
centrifugation at 100,000 x g in a Ti 50 rotor in a Beckman 
model L3-50 ultracentrifuge for 60 min. The pellet was the 
microsomal fraction and it was resuspended using a Kontes 
tube in one volume of the same buffer. The microsomal 
suspension was then stored at -80°C until analysis. 
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APPENDIX B; CHOLESTEROL DETERMINATION 
Materials 
Assay solution; 
sodium cholate 3. 0 mmol/1 
4-aminoantipyrine 0. 82 mmol/1 
phenol 14. 0 mmol/1 
Na2HP0^ 50. 0 mmol/1 
NaH2P04 50. 0 mmol/1 
carbowax-6000 0. 17 mmol/1 
cholesterol ester hydrolase 33 U/1 
cholesterol oxidase 117 U/1 
peroxidase 67000 U/1 
10% triton X-100 20 ml/1 
pH 7.0 
0.9% NaCl 
Cholesterol standard (50 and 200 mg/dl) 
Procedure 
One milliliter of assay solution was added to 20 u l  of 
serum or sample. Blank was prepared by substituting water 
for sample. The resulting solution was incubated at 37°C 
for 15 min. Then, 1 ml of 0.9% NaCl was added and the 
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spectrophotometric reading at 500 nm was recorded using a 
Beckman quartz spectrophotometer, model DU. The amount of 
cholesterol present was calculated using the standard as the 
reference. Free cholesterol was determined using the same 
procedure except that cholesterol ester hydrolase was 
omitted from the assay solution. 
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APPENDIX C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE 
ASSAY 
Materials 
0.05 M potassium phosphate buffer (pH 7.5) containing 0.3 M 
KCl, 1.0 mM EDTA and 5.0 mM dithiothreitol 
NADPH generating system; 4.5 fxmol of glucose-6-phosphate, 
0.3 lU of glucose-6-phosphate dehydrogenase, 0.45 jumol of 
NADP^ and 3.6 fxmol of EDTA in 30 nl of water 
^^C-HMG CoA: 1.38 juCi/jumol, 50 nmol/20 ixl of water 
^H-mevalonolactone: 6.7 Ci/mmol, 2 x 10^ dpm/10 jul 
of benzene 
Silica gel thin layer chromatography (TLC) sheet (0.1 mm 
thickness, 20 x 20 cm, Eastman Kodak Company, Rochester, 
NY) 
Bray's solution (Research Products International, Mount 
Prospect, IL) 
Procedure 
To 100 jul of sample which had been properly diluted 
with potassium phosphate buffer, 20 /ul of ^^C-HMG CoA and 30 
Ml of NADPH generating system were added. Blank was 
prepared by replacing sample with potassium phosphate 
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buffer. After incubation at 37°C for 30 min, the reaction 
was stopped by addition of 15 m1 of 6 N HCl. Ten 
microliters of ^H-mevalonolactone was added as an internal 
standard and the sample was incubated again at 37°C for 30 
min for complete lactonization. The sample was centrifuged 
in a Beckman microfuge for 1 min to sediment denatured 
protein. The supernatant was applied to an activated silica 
gel TLC sheet which then was developed in benzene/acetone 
(1:1, v/v). The mevalonolactone region (Rf 0.5-0.9) was 
scraped off, Bray's solution was added and the radioactivity 
was counted in a double channel (^H and scintillation 
counter (Packard TRI-CARB 2425 liquid scintillation 
spectrometer). The enzyme activity was calculated as amount 
of mevalonate formed. 
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APPENDIX D: CHOLESTEROL 7a-HYDR0XYLASE ASSAY 
Materials 
^^C-cholesterol; pre-purified by thin layer chromatography 
using benzene/ethyl acetate (2:3, v/v) as the developing 
solvent, 2 x 10^ cpm/150 nl water, contained 0.36 mg 
of Tween 80 
NADPH generating system; 0.75 mM NADP"*", 3 mM glucose-6-
phosphate, and 1 U/ml of glucose-6-phosphate 
dehydrogenase 
Homogenizing buffer; 0.1 M potassium phosphate buffer 
(pH 7.4) containing 0.25 M sucrose, 0.03 M nicotinamide, 
0.001 M dithiothreitol and 0.001 M disodium EDTA 
Assay buffer: 0.1 M potassium phosphate buffer (pH 7.4) 
containing 35 mM cysteamine 
4.5 mM MgCl2 
Silica gel TLC plates (Fisher Scientific Company, 0.25 mm 
in thickness, 20 x 20 cm ) 
7a-hydroxycholesterol (Steraloid Company) 
Scintisol (Isolab, Akron, OH) 
162 
Procedure 
The assay solution containing 300 i x l  of assay buffer, 
150 Atl of ^^C-cholesterol suspension, 300 jul of sample in 
homogenizing buffer and 150 nl of NADPH generating system 
was incubated at 37°C for 40 min. Two milliliters of 
ethanol was added to stop the reaction and the sterols were 
extracted twice with 20 ml of petroleum ether. The extract 
was evaporated to dryness with nitrogen and reconstituted in 
0.125 ml of benzene/methanol (4:1, v/v). The solution was 
pipeted as a streak on an activated TLC plate. 
7a-hydroxycholesterol standard was added to each streak for 
later identification. The plate was developed in 
benzene/ethyl acetate (2:3, v/v). 7a-hydroxycholesterol 
appeared blue and cholesterol pink after spraying with 50% 
sulfuric acid in water and heating. The 
7a-hydroxycholesterol band and the top cholesterol area were 
scraped off. Eight milliliters of Scintisol were added to 
each sample and the radioactivity was counted in a Packard 
TRI-CARB 2425 liquid scintillation spectrometer. The enzyme 
activity was calculated as percentage conversion of 
cholesterol to 7a-hydroxycholesterol. 
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APPENDIX E; PROTEIN DETERMINATION 
Materials 
10% sodium dodecyl sulfate (SDS) 
0.15% deoxycholate (DOC) 
72% trichloroacetic acid (TCA) 
Copper-tartrate-carbonate (CTC): 0.01% copper sulfate, 
0.2% potassium tartrate and 10% sodium carbonate 
0.8 N NaOH 
Reagent A; 
CTC:NaOH;SDS;H20=l:1:1:1 
Reagent B: 
2 N Folin-Ciocalteau phenol:H20=1;5 
Bovine serum albumin (BSA) (5-100 ug/ml) 
Procedure 
One tenth milliliter of DOC was added to 1 ml of 
properly diluted sample (5-100 nq protein). After 10 min at 
room temperature, 0.1 ml of TCA was added. The sample was 
centrifuged at 3,000 x g for 15 min. The supernatant was 
discarded and the pellet was brought to 1 ml with distilled 
water. One milliliter of reagent A was added and the 
solution was allowed to stand at room temperature for 10 
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min. Then, 0.5 ml of reagent B was added. The absorbance 
at 750 nm was recorded after 30 min at room temperature 
using a Beckman quartz spectrophotometer. A calibration 
curve was prepared using BSA as the standard, and the 
concentration of the sample was read from the curve. 
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APPENDIX F: ENZYMATIC DETERMINATION OF TOTAL BILE ACIDS 
Materials ' 
0.01 M potassium phosphate buffer, pH 7.2 
0.1 M sodium pyrophosphate, pH 9.5 
0.1 M sodium dodecyl sulfate (SDS) 
3.2% hydrazine hydrate, pH 9.5 
6.8 jumol/ml /3-NAD 
3a-hydroxysteroid dehydrogenase, 1 U/ml of 0.01 M potassium 
phosphate buffer 
sodium cholate standard (5-50 /ig/O,! ml methanol) 
Procedure 
One and four tenths milliliters (1.4 ml) of 
pyrophosphate buffer, 1.0 ml of hydrazine hydrate, 0.1 ml of 
/3-NAD, and 0.3 ml of enzyme solution were added to 0.1 ml of 
sample in methanol. After incubation at 26°C for 35 min, 
0.1 ml of SDS was added to stop the reaction and clear the 
solution. A blank was set up for each sample by adding the 
enzyme only after the SDS. Absorbance at 340 nm was 
recorded using a Beckman quartz spectrophotometer, model DU. 
Since one mole of bile acid forms one mole of NADH in the 
presence of 3a-hydroxysteroid dehydrogenase, the amount of 
bile acids present is calculated from the following formula: 
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amount of bile acids (pmol) = (A x 3)/6.22 
where A = increase in extinction 
6.22 X 10® = molar extinction of NADH at 340 nm 
167 
ACKNOWLEDGEMENTS 
I would like to thank my advisor, Professor J. Dupont, 
for her guidance, constant enthusiasm, and encouragement 
throughout my research. I also wish to express my gratitude 
to Professor R. C. Seagrave and L. Patterson for 
constructing the mathematical model and analyzing the 
kinetic data, Professor H. M. Stahr for his time and 
teaching me how to tackle problems in chemical analysis. 
Professor P. A. Garcia for helping with the dietary design, 
and Professors D. Beitz and E. A. Schafer for sitting in my 
committee. The assistance of J. Stewart, B. Krumdhardt, K. 
C. Lee, K. Hanson, C. Shriver, and J. Ryoo is gratefully 
acknowledged. Finally, I thank the animal care staff, R. 
Koschorreck and P. Whitson, for breeding the mice. The 
research was supported by the Iowa Agriculture and Home 
Economics Experiment Station, Project 2571, a contributing 
project to North Central Regional Research Project NC-167. 
